<?xml version="1.0" encoding="iso-8859-1" ?>
<PASBIO>
    <framesest>
        <predicate lemma="abolish">
            <roleset id="abolish.01" name="" wordnet="1">
                <roles>
                    <role n="0" descr="causer/agent &#x09;&#x09;&#x09; &#x09;// change at molecular level //&#x0A;" />
                    <role n="1" descr="entity abolished &#x09;&#x09;&#x09;// normal transcription, normal splicing //&#x0A;" />
                </roles>
                <example src="EGRAM" no="0">
                    <text>A G-to-A transition at the first nucleotide of intron 2 of patient 1 abolished normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="EGRAM" no="1">
                    <text>A G-to-A transition at the first nucleotide of intron 2 of patient 1 abolishes normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="EGRAM" no="2">
                    <text>Alp activity is abolished by Insertions which interrupt this open reading frame.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="EGRAM" no="3">
                    <text>Alp activity was abolished by Insertions which interrupt this open reading frame.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="EGRAM" no="4">
                    <text>Co-administered DM, which is able to abolish completely the CPP effect induced by morphine, had no effect on morphine-induced behavioral sensitization.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="EGRAM" no="5">
                    <text>Co-administered DM, which was able to abolish completely the CPP effect induced by morphine, had no effect on morphine-induced behavioral sensitization.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="EGRAM" no="6">
                    <text>Disruption of rpoS, mlrA or csgA, and the curli subunit gene abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="EGRAM" no="7">
                    <text>Disruption of rpoS, mlrA or csgA, and the curli subunit gene abolished HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="EGRAM" no="8">
                    <text>Formation of liver metastases in mice is abolished by linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="EGRAM" no="9">
                    <text>Formation of liver metastases in mice was abolished by linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="EGRAM" no="10">
                    <text>Furthermore, acid resistance in stationary-phase cells has been completely abolished by the deletion of yhiE, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="EGRAM" no="11">
                    <text>Furthermore, acid resistance in stationary-phase cells is completely abolished by the deletion of yhiE, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="EGRAM" no="12">
                    <text>Furthermore, the deletion of yhiE completely abolishes acid resistance in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="EGRAM" no="13">
                    <text>Furthermore, the deletion of yhiE has completely abolished acid resistance in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="EGRAM" no="14">
                    <text>Furthermore, the deletion of yhiE will completely abolish acid resistance in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="EGRAM" no="15">
                    <text>Groucho binding is abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid (Jimnez et al., 1999).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="EGRAM" no="16">
                    <text>Groucho binding was abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid (Jimnez et al., 1999).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="EGRAM" no="17">
                    <text>HA and curli production by strain chi7122 are abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="EGRAM" no="18">
                    <text>HA and curli production by strain chi7122 can be abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="EGRAM" no="19">
                    <text>HA and curli production by strain chi7122 has been abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="EGRAM" no="20">
                    <text>HA and curli production by strain chi7122 will be abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="EGRAM" no="21">
                    <text>However, its BCFA biosynthesis is not abolished by this complete removal of FabD from the crude FAS, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="22">
                    <text>However, its BCFA biosynthesis was not abolished by this complete removal of FabD from the crude FAS, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="23">
                    <text>However, this complete removal of FabD from the crude FAS does not abolish its BCFA biosynthesis, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="24">
                    <text>However, this complete removal of FabD from the crude FAS will not abolish its BCFA biosynthesis, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="EGRAM" no="25">
                    <text>In addition, deletion of the distal tor box (box1) abolished torC induction whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="EGRAM" no="26">
                    <text>In addition, deletion of the distal tor box (box1) can abolish torC induction whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="EGRAM" no="27">
                    <text>In addition, deletion of the distal tor box (box1) has abolished torC induction whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="EGRAM" no="28">
                    <text>In addition, deletion of the distal tor box (box1) is able to abolish torC induction whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="EGRAM" no="29">
                    <text>In addition, deletion of the distal tor box (box1) will abolish torC induction whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="EGRAM" no="30">
                    <text>In contrast, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 abolished transcriptional stimulation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="EGRAM" no="31">
                    <text>In contrast, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 abolishes transcriptional stimulation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="EGRAM" no="32">
                    <text>In contrast, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 can abolish transcriptional stimulation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="EGRAM" no="33">
                    <text>In contrast, transcriptional stimulation is abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="EGRAM" no="34">
                    <text>Insertions being able to abolish Alp activity interrupt this open reading frame.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="EGRAM" no="35">
                    <text>Insertions which abolished Alp activity interrupt this open reading frame.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="EGRAM" no="36">
                    <text>Insertions which has abolished Alp activity interrupt this open reading frame.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="EGRAM" no="37">
                    <text>Linomide and antibody-targeted superantigen therapy abolished formation of liver metastases in mice.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="EGRAM" no="38">
                    <text>Linomide and antibody-targeted superantigen therapy can abolish formation of liver metastases in mice.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="EGRAM" no="39">
                    <text>Linomide and antibody-targeted superantigen therapy will abolish formation of liver metastases in mice.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="EGRAM" no="40">
                    <text>Mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolished groucho binding (Jimnez et al., 1999).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="EGRAM" no="41">
                    <text>Mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolishes groucho binding (Jimnez et al., 1999).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="EGRAM" no="42">
                    <text>Mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid can abolish groucho binding (Jimnez et al., 1999).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="EGRAM" no="43">
                    <text>Mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid will abolish groucho binding (Jimnez et al., 1999).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="EGRAM" no="44">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp can completely abolishes synergy, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                    <arg n="M-ADV">completely</arg>
                </example>
                <example src="EGRAM" no="45">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp promoter completely abolishes synergy, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                    <arg n="M-ADV">completely</arg>
                </example>
                <example src="EGRAM" no="46">
                    <text>Mutations in the fhlA gene also abolish production of the hydrogenase activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="EGRAM" no="47">
                    <text>Mutations in the fhlA gene has also abolished production of the hydrogenase activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="EGRAM" no="48">
                    <text>Mutations in the fhlA gene will also abolish production of the hydrogenase activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="EGRAM" no="49">
                    <text>Normal LHX4 splicing is abolished by this intronic mutation, which segregates in a dominant and fully penetrant manner over three generations and activates two exonic cryptic splice sites, thereby predicting two different proteins deleted in their homeodomain sequence.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="EGRAM" no="50">
                    <text>Normal LHX4 splicing was abolished by this intronic mutation, which segregates in a dominant and fully penetrant manner over three generations and activates two exonic cryptic splice sites, thereby predicting two different proteins deleted in their homeodomain sequence.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="EGRAM" no="51">
                    <text>Normal splicing is abolished by a G-to-A transition at the first nucleotide of intron 2 of patient 1.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="EGRAM" no="52">
                    <text>Normal splicing was abolished by a G-to-A transition at the first nucleotide of intron 2 of patient 1.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="EGRAM" no="53">
                    <text>Noticeably, transcription at the rrn PC promoter by NEP-2 can be completely abolished if CDF2-B can not bind to the template, as obtained by the mutation M1 (Figure 4A, compare lanes 1 and 4; Figure 4C, compare Wt and M1).</text>
                    <arg n="1">transcription at the rrn PC promoter by NEP-2</arg>
                </example>
                <example src="EGRAM" no="54">
                    <text>Noticeably, transcription at the rrn PC promoter by NEP-2 was completely abolished if CDF2-B can not bind to the template, as obtained by the mutation M1 (Figure 4A, compare lanes 1 and 4; Figure 4C, compare Wt and M1).</text>
                    <arg n="1">transcription at the rrn PC promoter by NEP-2</arg>
                </example>
                <example src="EGRAM" no="55">
                    <text>One mutation abolished RNA expression from the altered allele.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="EGRAM" no="56">
                    <text>One mutation abolishes RNA expression from the altered allele.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="EGRAM" no="57">
                    <text>One mutation can abolish RNA expression from the altered allele.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="EGRAM" no="58">
                    <text>One mutation will abolish RNA expression from the altered allele.&#x09;</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="EGRAM" no="59">
                    <text>Our results showed that co-administered DM is able to abolish completely the CPP effect induced by morphine, but had no effect on morphine-induced behavioral sensitization.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="EGRAM" no="60">
                    <text>RNA expression is abolished by one mutation from the altered allele.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="EGRAM" no="61">
                    <text>RNA expression was abolished by one mutation from the altered allele.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="EGRAM" no="62">
                    <text>Synergy is completely abolished by mutation of the proximal GATA element in the context of the 700 or the 135 bp, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                    <arg n="M-ADV">completely</arg>
                </example>
                <example src="EGRAM" no="63">
                    <text>Synergy was completely abolished by mutation of the proximal GATA element in the context of the 700 or the 135 bp, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                    <arg n="M-ADV">completely</arg>
                </example>
                <example src="EGRAM" no="64">
                    <text>The A/T-rich mut sequence indicates that the A/T-rich element is abolished by the mutations.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="EGRAM" no="65">
                    <text>The A/T-rich mut sequence indicates that the A/T-rich element was abolished by the mutations.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="EGRAM" no="66">
                    <text>The A/T-rich mut sequence indicates that the mutations abolish the A/T-rich element.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="EGRAM" no="67">
                    <text>The A/T-rich mut sequence indicates that the mutations abolished the A/T-rich element.&#x09;</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="EGRAM" no="68">
                    <text>The A/T-rich mut sequence indicates the mutations can abolish the A/T-rich element.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="EGRAM" no="69">
                    <text>The CPP effect was able to be abolised by co-administered DM induced by morphine, but had no effect on morphine-induced behavioral sensitization.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="EGRAM" no="70">
                    <text>The cpx101 mutation abolished cpxA phosphatase activity and resulted in the accumulation of phosphorylated CpxR.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="EGRAM" no="71">
                    <text>The cpx101 mutation has abolished cpxA phosphatase activity and resulted in the accumulation of phosphorylated CpxR.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="EGRAM" no="72">
                    <text>The cpx101 mutation which abolished cpxA phosphatase activity has resulted in the accumulation of phosphorylated CpxR.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="EGRAM" no="73">
                    <text>The cpx101 mutation which abolishes cpxA phosphatase activity results in the accumulation of phosphorylated CpxR.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="EGRAM" no="74">
                    <text>The cpx101 mutation will abolish cpxA phosphatase activity and results in the accumulation of phosphorylated CpxR.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="EGRAM" no="75">
                    <text>The deletion of ydeP, ydeO, or yhiE which was induced by EvgA overexpression abolish this acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="EGRAM" no="76">
                    <text>The deletion of ydeP, ydeO, or yhiE which was induced by EvgA overexpression abolished this acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="EGRAM" no="77">
                    <text>The production of the hydrogenase activity associated with formate hydrogenlyase activity are abolished by mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="EGRAM" no="78">
                    <text>The production of the hydrogenase activity associated with formate hydrogenlyase activity can be abolished by mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="EGRAM" no="79">
                    <text>This acid resistance has been abolished by deletion of ydeP, ydeO, or yhiE, which was induced by EvgA overexpression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="EGRAM" no="80">
                    <text>This acid resistance is abolished by deletion of ydeP, ydeO, or yhiE, which was induced by EvgA overexpression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="EGRAM" no="81">
                    <text>This acid resistance will be abolished by deletion of ydeP, ydeO, or yhiE, which was induced by EvgA overexpression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="EGRAM" no="82">
                    <text>This intronic mutation, which abolished normal LHX4 splicing, activates two exonic cryptic splice sites and thereby predicts two different proteins deleted in their homeodomain sequence.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="EGRAM" no="83">
                    <text>This intronic mutation, which abolishes normal LHX4 splicing, activates two exonic cryptic splice sites and thereby predicts two different proteins deleted in their homeodomain sequence.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="EGRAM" no="84">
                    <text>This intronic mutation, which segregates in a dominant and fully penetrant manner over three generations, abolished normal LHX4 splicing and activates two exonic cryptic splice sites, thereby predicting two different proteins deleted in their homeodomain sequence.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="EMBO" no="1">
                    <text>Groucho binding was, however, abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid (Jimnez et al., 1999).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="EMBO" no="2">
                    <text>In contrast, transcriptional stimulation was abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="EMBO" no="3">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp promoter completely abolished synergy, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                    <arg n="M-ADV">completely</arg>
                </example>
                <example src="EMBO" no="4">
                    <text>Noticeably, transcription at the rrn PC promoter by NEP-2 is completely abolished if CDF2-B can not bind to the template, as obtained by the mutation M1 (Figure 4A, compare lanes 1 and 4; Figure 4C, compare Wt and M1).</text>
                    <arg n="1">transcription at the rrn PC promoter by NEP-2</arg>
                </example>
                <example src="EMBO" no="5">
                    <text>The A/T-rich mut sequence indicates the mutations introduced to abolish the A/T-rich element.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="GREC" no="1">
                    <text>Furthermore, the deletion of yhiE completely abolished acid resistance in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="GREC" no="2">
                    <text>HA and curli production by strain chi7122 were abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="GREC" no="3">
                    <text>In addition, deletion of the distal tor box (box1) abolishes torC induction whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="GREC" no="4">
                    <text>Insertions which abolish Alp activity interrupt this open reading frame.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="GREC" no="5">
                    <text>Mutations in the fhlA gene also abolished production of the hydrogenase activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="GREC" no="6">
                    <text>The cpx101 mutation abolishes cpxA phosphatase activity and results in the accumulation of phosphorylated CpxR.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="GREC" no="7">
                    <text>This acid resistance was abolished by deletion of ydeP, ydeO, or yhiE, which was induced by EvgA overexpression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="MEDLINE" no="1">
                    <text>Determining the complete exon-intron structure of JAG1 allowed detailed mutational analysis of DNA samples from non-deletion AGS patients, revealing three frame-shift mutations, two splice donor mutations and one mutation abolishing RNA expression from the altered allele.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="MEDLINE" no="2">
                    <text>However, this complete removal of FabD from the crude FAS did not abolish its BCFA biosynthesis, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                    <arg n="M-NEG">not</arg>
                </example>
                <example src="MEDLINE" no="3">
                    <text>Linomide and antibody-targeted superantigen therapy abolishes formation of liver metastases in mice.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="MEDLINE" no="4">
                    <text>Our results showed that co-administered DM was able to abolish completely the CPP effect induced by morphine, but had no effect on morphine-induced behavioral sensitization.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="MEDLINE" no="5">
                    <text>Patient 1 has a G-to-A transition at the first nucleotide of intron 2, which abolishes normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="MEDLINE" no="6">
                    <text>This intronic mutation, which segregates in a dominant and fully penetrant manner over three generations, abolishes normal LHX4 splicing and activates two exonic cryptic splice sites, thereby predicting two different proteins deleted in their homeodomain sequence.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="PERMUTATE" no="1">
                    <text>Alp activity are abolished by Insertions.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="2">
                    <text>Alp activity can be abolished by Insertions.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="3">
                    <text>Alp activity has been abolished by Insertions, which was induced by EvgA overexpression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="4">
                    <text>Alp activity has been abolished by Insertions.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="5">
                    <text>Alp activity is abolished by Insertions, which was induced by EvgA overexpression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="6">
                    <text>Alp activity were abolished by Insertions.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="7">
                    <text>Alp activity will be abolished by Insertions, which was induced by EvgA overexpression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="8">
                    <text>Alp activity will be abolished by Insertions.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="9">
                    <text>Furthermore, Alp activity in stationary-phase cells has been completely abolished by Insertions, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="10">
                    <text>Furthermore, Alp activity in stationary-phase cells is completely abolished by Insertions, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="11">
                    <text>Furthermore, HA and curli production by strain chi7122 in stationary-phase cells has been completely abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="12">
                    <text>Furthermore, HA and curli production by strain chi7122 in stationary-phase cells has been completely abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="13">
                    <text>Furthermore, HA and curli production by strain chi7122 in stationary-phase cells is completely abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="14">
                    <text>Furthermore, HA and curli production by strain chi7122 in stationary-phase cells is completely abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="15">
                    <text>Furthermore, Insertions completely abolished Alp activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="16">
                    <text>Furthermore, Insertions completely abolishes Alp activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="17">
                    <text>Furthermore, Insertions has completely abolished Alp activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="18">
                    <text>Furthermore, Insertions will completely abolish Alp activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="19">
                    <text>Furthermore, Linomide and antibody-targeted superantigen therapy completely abolished formation of liver metastases in mice in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="20">
                    <text>Furthermore, Linomide and antibody-targeted superantigen therapy completely abolishes formation of liver metastases in mice in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="21">
                    <text>Furthermore, Linomide and antibody-targeted superantigen therapy has completely abolished formation of liver metastases in mice in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="22">
                    <text>Furthermore, Linomide and antibody-targeted superantigen therapy will completely abolish formation of liver metastases in mice in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="23">
                    <text>Furthermore, Mutation of the proximal GATA element in the context of the 700 or the 135 bp completely abolished synergy in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="24">
                    <text>Furthermore, Mutation of the proximal GATA element in the context of the 700 or the 135 bp completely abolishes synergy in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="25">
                    <text>Furthermore, Mutation of the proximal GATA element in the context of the 700 or the 135 bp has completely abolished synergy in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="26">
                    <text>Furthermore, Mutation of the proximal GATA element in the context of the 700 or the 135 bp will completely abolish synergy in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="27">
                    <text>Furthermore, Mutations in the fhlA gene completely abolished production of the hydrogenase activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="28">
                    <text>Furthermore, Mutations in the fhlA gene completely abolishes production of the hydrogenase activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="29">
                    <text>Furthermore, Mutations in the fhlA gene has completely abolished production of the hydrogenase activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="30">
                    <text>Furthermore, Mutations in the fhlA gene will completely abolish production of the hydrogenase activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="31">
                    <text>Furthermore, This acid resistance in stationary-phase cells has been completely abolished by deletion of ydeP, ydeO, or yhiE, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="32">
                    <text>Furthermore, This acid resistance in stationary-phase cells is completely abolished by deletion of ydeP, ydeO, or yhiE, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="33">
                    <text>Furthermore, deletion of the distal tor box (box1) completely abolished torC induction in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="34">
                    <text>Furthermore, deletion of the distal tor box (box1) completely abolishes torC induction in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="35">
                    <text>Furthermore, deletion of the distal tor box (box1) has completely abolished torC induction in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="36">
                    <text>Furthermore, deletion of the distal tor box (box1) will completely abolish torC induction in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="37">
                    <text>Furthermore, deletion of ydeP, ydeO, or yhiE completely abolished This acid resistance in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="38">
                    <text>Furthermore, deletion of ydeP, ydeO, or yhiE completely abolishes This acid resistance in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="39">
                    <text>Furthermore, deletion of ydeP, ydeO, or yhiE has completely abolished This acid resistance in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="40">
                    <text>Furthermore, deletion of ydeP, ydeO, or yhiE in stationary-phase cells has been completely abolished by This acid resistance, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="41">
                    <text>Furthermore, deletion of ydeP, ydeO, or yhiE in stationary-phase cells is completely abolished by This acid resistance, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="42">
                    <text>Furthermore, deletion of ydeP, ydeO, or yhiE will completely abolish This acid resistance in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="43">
                    <text>Furthermore, disruption of rpoS, mlrA or csgA, and the curli subunit gene completely abolished HA and curli production by strain chi7122 in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="44">
                    <text>Furthermore, disruption of rpoS, mlrA or csgA, and the curli subunit gene completely abolishes HA and curli production by strain chi7122 in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="45">
                    <text>Furthermore, disruption of rpoS, mlrA or csgA, and the curli subunit gene has completely abolished HA and curli production by strain chi7122 in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="46">
                    <text>Furthermore, disruption of rpoS, mlrA or csgA, and the curli subunit gene will completely abolish HA and curli production by strain chi7122 in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="47">
                    <text>Furthermore, disruption of rpoS, mlrA or csgA, the curli subunit gene completely abolished HA and curli production by strain chi7122 in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="48">
                    <text>Furthermore, disruption of rpoS, mlrA or csgA, the curli subunit gene completely abolishes HA and curli production by strain chi7122 in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="49">
                    <text>Furthermore, disruption of rpoS, mlrA or csgA, the curli subunit gene has completely abolished HA and curli production by strain chi7122 in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="50">
                    <text>Furthermore, disruption of rpoS, mlrA or csgA, the curli subunit gene will completely abolish HA and curli production by strain chi7122 in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="51">
                    <text>Furthermore, formation of liver metastases in mice in stationary-phase cells has been completely abolished by Linomide and antibody-targeted superantigen therapy, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="52">
                    <text>Furthermore, formation of liver metastases in mice in stationary-phase cells is completely abolished by Linomide and antibody-targeted superantigen therapy, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="53">
                    <text>Furthermore, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 completely abolished transcriptional stimulation in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="54">
                    <text>Furthermore, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 completely abolishes transcriptional stimulation in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="55">
                    <text>Furthermore, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 has completely abolished transcriptional stimulation in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="56">
                    <text>Furthermore, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 will completely abolish transcriptional stimulation in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="57">
                    <text>Furthermore, its BCFA biosynthesis in stationary-phase cells has been completely abolished by this complete removal of FabD from the crude FAS, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="58">
                    <text>Furthermore, its BCFA biosynthesis in stationary-phase cells is completely abolished by this complete removal of FabD from the crude FAS, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="59">
                    <text>Furthermore, production of the hydrogenase activity in stationary-phase cells has been completely abolished by Mutations in the fhlA gene, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="60">
                    <text>Furthermore, production of the hydrogenase activity in stationary-phase cells is completely abolished by Mutations in the fhlA gene, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="61">
                    <text>Furthermore, synergy in stationary-phase cells has been completely abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="62">
                    <text>Furthermore, synergy in stationary-phase cells is completely abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="63">
                    <text>Furthermore, the A/T-rich element in stationary-phase cells has been completely abolished by the mutations, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="64">
                    <text>Furthermore, the A/T-rich element in stationary-phase cells is completely abolished by the mutations, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="65">
                    <text>Furthermore, the mutations completely abolished the A/T-rich element in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="66">
                    <text>Furthermore, the mutations completely abolishes the A/T-rich element in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="67">
                    <text>Furthermore, the mutations has completely abolished the A/T-rich element in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="68">
                    <text>Furthermore, the mutations will completely abolish the A/T-rich element in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="69">
                    <text>Furthermore, this complete removal of FabD from the crude FAS completely abolished its BCFA biosynthesis in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="70">
                    <text>Furthermore, this complete removal of FabD from the crude FAS completely abolishes its BCFA biosynthesis in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="71">
                    <text>Furthermore, this complete removal of FabD from the crude FAS has completely abolished its BCFA biosynthesis in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="72">
                    <text>Furthermore, this complete removal of FabD from the crude FAS will completely abolish its BCFA biosynthesis in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="73">
                    <text>Furthermore, torC induction in stationary-phase cells has been completely abolished by deletion of the distal tor box (box1), suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="74">
                    <text>Furthermore, torC induction in stationary-phase cells is completely abolished by deletion of the distal tor box (box1), suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="75">
                    <text>Furthermore, transcriptional stimulation in stationary-phase cells has been completely abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="76">
                    <text>Furthermore, transcriptional stimulation in stationary-phase cells is completely abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="77">
                    <text>HA and curli production by strain chi7122 are abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="78">
                    <text>HA and curli production by strain chi7122 can be abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="79">
                    <text>HA and curli production by strain chi7122 has been abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="80">
                    <text>HA and curli production by strain chi7122 has been abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="81">
                    <text>HA and curli production by strain chi7122 has been abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="82">
                    <text>HA and curli production by strain chi7122 is abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene which interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="83">
                    <text>HA and curli production by strain chi7122 is abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="84">
                    <text>HA and curli production by strain chi7122 is abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene which interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="85">
                    <text>HA and curli production by strain chi7122 is abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="86">
                    <text>HA and curli production by strain chi7122 was abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene which interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="87">
                    <text>HA and curli production by strain chi7122 was abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene which interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="88">
                    <text>HA and curli production by strain chi7122 were abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="89">
                    <text>HA and curli production by strain chi7122 will be abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="90">
                    <text>HA and curli production by strain chi7122 will be abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="91">
                    <text>HA and curli production by strain chi7122 will be abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="92">
                    <text>However, Alp activity is not abolished by Insertions, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="93">
                    <text>However, Alp activity was not abolished by Insertions, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="94">
                    <text>However, HA and curli production by strain chi7122 is not abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="95">
                    <text>However, HA and curli production by strain chi7122 is not abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="96">
                    <text>However, HA and curli production by strain chi7122 was not abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="97">
                    <text>However, HA and curli production by strain chi7122 was not abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="98">
                    <text>However, Insertions did not abolish Alp activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="99">
                    <text>However, Insertions does not abolish Alp activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="100">
                    <text>However, Insertions will not abolish Alp activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="101">
                    <text>However, Linomide and antibody-targeted superantigen therapy did not abolish formation of liver metastases in mice, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="102">
                    <text>However, Linomide and antibody-targeted superantigen therapy does not abolish formation of liver metastases in mice, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="103">
                    <text>However, Linomide and antibody-targeted superantigen therapy will not abolish formation of liver metastases in mice, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="104">
                    <text>However, Mutation of the proximal GATA element in the context of the 700 or the 135 bp did not abolish synergy, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="105">
                    <text>However, Mutation of the proximal GATA element in the context of the 700 or the 135 bp does not abolish synergy, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="106">
                    <text>However, Mutation of the proximal GATA element in the context of the 700 or the 135 bp will not abolish synergy, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="107">
                    <text>However, Mutations in the fhlA gene did not abolish production of the hydrogenase activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="108">
                    <text>However, Mutations in the fhlA gene does not abolish production of the hydrogenase activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="109">
                    <text>However, Mutations in the fhlA gene will not abolish production of the hydrogenase activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="110">
                    <text>However, This acid resistance did not abolish deletion of ydeP, ydeO, or yhiE, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="111">
                    <text>However, This acid resistance does not abolish deletion of ydeP, ydeO, or yhiE, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="112">
                    <text>However, This acid resistance is not abolished by deletion of ydeP, ydeO, or yhiE, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="113">
                    <text>However, This acid resistance was not abolished by deletion of ydeP, ydeO, or yhiE, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="114">
                    <text>However, This acid resistance will not abolish deletion of ydeP, ydeO, or yhiE, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="115">
                    <text>However, acid resistance is not abolished by the deletion of yhiE, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="116">
                    <text>However, acid resistance was not abolished by the deletion of yhiE, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="117">
                    <text>However, deletion of the distal tor box (box1) did not abolish torC induction, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="118">
                    <text>However, deletion of the distal tor box (box1) does not abolish torC induction, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="119">
                    <text>However, deletion of the distal tor box (box1) will not abolish torC induction, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="120">
                    <text>However, deletion of ydeP, ydeO, or yhiE did not abolish This acid resistance, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="121">
                    <text>However, deletion of ydeP, ydeO, or yhiE does not abolish This acid resistance, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="122">
                    <text>However, deletion of ydeP, ydeO, or yhiE is not abolished by This acid resistance, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="123">
                    <text>However, deletion of ydeP, ydeO, or yhiE was not abolished by This acid resistance, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="124">
                    <text>However, deletion of ydeP, ydeO, or yhiE will not abolish This acid resistance, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="125">
                    <text>However, disruption of rpoS, mlrA or csgA, and the curli subunit gene did not abolish HA and curli production by strain chi7122, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="126">
                    <text>However, disruption of rpoS, mlrA or csgA, and the curli subunit gene does not abolish HA and curli production by strain chi7122, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="127">
                    <text>However, disruption of rpoS, mlrA or csgA, and the curli subunit gene will not abolish HA and curli production by strain chi7122, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="128">
                    <text>However, disruption of rpoS, mlrA or csgA, the curli subunit gene did not abolish HA and curli production by strain chi7122, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="129">
                    <text>However, disruption of rpoS, mlrA or csgA, the curli subunit gene does not abolish HA and curli production by strain chi7122, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="130">
                    <text>However, disruption of rpoS, mlrA or csgA, the curli subunit gene will not abolish HA and curli production by strain chi7122, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="131">
                    <text>However, formation of liver metastases in mice is not abolished by Linomide and antibody-targeted superantigen therapy, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="132">
                    <text>However, formation of liver metastases in mice was not abolished by Linomide and antibody-targeted superantigen therapy, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="133">
                    <text>However, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 did not abolish transcriptional stimulation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="134">
                    <text>However, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 does not abolish transcriptional stimulation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="135">
                    <text>However, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 will not abolish transcriptional stimulation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="136">
                    <text>However, production of the hydrogenase activity is not abolished by Mutations in the fhlA gene, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="137">
                    <text>However, production of the hydrogenase activity was not abolished by Mutations in the fhlA gene, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="138">
                    <text>However, synergy is not abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="139">
                    <text>However, synergy was not abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="140">
                    <text>However, the A/T-rich element is not abolished by the mutations, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="141">
                    <text>However, the A/T-rich element was not abolished by the mutations, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="142">
                    <text>However, the deletion of yhiE did not abolish acid resistance, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="143">
                    <text>However, the deletion of yhiE does not abolish acid resistance, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="144">
                    <text>However, the deletion of yhiE will not abolish acid resistance, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="145">
                    <text>However, the mutations did not abolish the A/T-rich element, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="146">
                    <text>However, the mutations does not abolish the A/T-rich element, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="147">
                    <text>However, the mutations will not abolish the A/T-rich element, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="148">
                    <text>However, torC induction is not abolished by deletion of the distal tor box (box1), but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="149">
                    <text>However, torC induction was not abolished by deletion of the distal tor box (box1), but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="150">
                    <text>However, transcriptional stimulation is not abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="151">
                    <text>However, transcriptional stimulation was not abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="152">
                    <text>In addition, Insertions abolished Alp activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="153">
                    <text>In addition, Insertions abolishes Alp activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="154">
                    <text>In addition, Insertions can abolish Alp activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="155">
                    <text>In addition, Insertions has abolished Alp activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="156">
                    <text>In addition, Insertions is able to abolish Alp activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="157">
                    <text>In addition, Insertions will abolish Alp activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="158">
                    <text>In addition, Linomide and antibody-targeted superantigen therapy abolished formation of liver metastases in mice whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="159">
                    <text>In addition, Linomide and antibody-targeted superantigen therapy abolishes formation of liver metastases in mice whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="160">
                    <text>In addition, Linomide and antibody-targeted superantigen therapy can abolish formation of liver metastases in mice whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="161">
                    <text>In addition, Linomide and antibody-targeted superantigen therapy has abolished formation of liver metastases in mice whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="162">
                    <text>In addition, Linomide and antibody-targeted superantigen therapy is able to abolish formation of liver metastases in mice whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="163">
                    <text>In addition, Linomide and antibody-targeted superantigen therapy will abolish formation of liver metastases in mice whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="164">
                    <text>In addition, Mutation of the proximal GATA element in the context of the 700 or the 135 bp abolished synergy whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="165">
                    <text>In addition, Mutation of the proximal GATA element in the context of the 700 or the 135 bp abolishes synergy whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="166">
                    <text>In addition, Mutation of the proximal GATA element in the context of the 700 or the 135 bp can abolish synergy whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="167">
                    <text>In addition, Mutation of the proximal GATA element in the context of the 700 or the 135 bp has abolished synergy whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="168">
                    <text>In addition, Mutation of the proximal GATA element in the context of the 700 or the 135 bp is able to abolish synergy whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="169">
                    <text>In addition, Mutation of the proximal GATA element in the context of the 700 or the 135 bp will abolish synergy whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="170">
                    <text>In addition, Mutations in the fhlA gene abolished production of the hydrogenase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="171">
                    <text>In addition, Mutations in the fhlA gene abolishes production of the hydrogenase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="172">
                    <text>In addition, Mutations in the fhlA gene can abolish production of the hydrogenase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="173">
                    <text>In addition, Mutations in the fhlA gene has abolished production of the hydrogenase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="174">
                    <text>In addition, Mutations in the fhlA gene is able to abolish production of the hydrogenase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="175">
                    <text>In addition, Mutations in the fhlA gene will abolish production of the hydrogenase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="176">
                    <text>In addition, This acid resistance abolished deletion of ydeP, ydeO, or yhiE whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="177">
                    <text>In addition, This acid resistance abolishes deletion of ydeP, ydeO, or yhiE whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="178">
                    <text>In addition, This acid resistance can abolish deletion of ydeP, ydeO, or yhiE whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="179">
                    <text>In addition, This acid resistance has abolished deletion of ydeP, ydeO, or yhiE whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="180">
                    <text>In addition, This acid resistance is able to abolish deletion of ydeP, ydeO, or yhiE whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="181">
                    <text>In addition, This acid resistance will abolish deletion of ydeP, ydeO, or yhiE whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="182">
                    <text>In addition, deletion of ydeP, ydeO, or yhiE abolished This acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="183">
                    <text>In addition, deletion of ydeP, ydeO, or yhiE abolishes This acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="184">
                    <text>In addition, deletion of ydeP, ydeO, or yhiE can abolish This acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="185">
                    <text>In addition, deletion of ydeP, ydeO, or yhiE has abolished This acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="186">
                    <text>In addition, deletion of ydeP, ydeO, or yhiE is able to abolish This acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="187">
                    <text>In addition, deletion of ydeP, ydeO, or yhiE will abolish This acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="188">
                    <text>In addition, disruption of rpoS, mlrA or csgA, and the curli subunit gene abolished HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="189">
                    <text>In addition, disruption of rpoS, mlrA or csgA, and the curli subunit gene abolishes HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="190">
                    <text>In addition, disruption of rpoS, mlrA or csgA, and the curli subunit gene can abolish HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="191">
                    <text>In addition, disruption of rpoS, mlrA or csgA, and the curli subunit gene has abolished HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="192">
                    <text>In addition, disruption of rpoS, mlrA or csgA, and the curli subunit gene is able to abolish HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="193">
                    <text>In addition, disruption of rpoS, mlrA or csgA, and the curli subunit gene will abolish HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="194">
                    <text>In addition, disruption of rpoS, mlrA or csgA, the curli subunit gene abolished HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="195">
                    <text>In addition, disruption of rpoS, mlrA or csgA, the curli subunit gene abolishes HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="196">
                    <text>In addition, disruption of rpoS, mlrA or csgA, the curli subunit gene can abolish HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="197">
                    <text>In addition, disruption of rpoS, mlrA or csgA, the curli subunit gene has abolished HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="198">
                    <text>In addition, disruption of rpoS, mlrA or csgA, the curli subunit gene is able to abolish HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="199">
                    <text>In addition, disruption of rpoS, mlrA or csgA, the curli subunit gene will abolish HA and curli production by strain chi7122 whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="200">
                    <text>In addition, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 abolished transcriptional stimulation whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="201">
                    <text>In addition, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 abolishes transcriptional stimulation whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="202">
                    <text>In addition, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 can abolish transcriptional stimulation whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="203">
                    <text>In addition, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 has abolished transcriptional stimulation whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="204">
                    <text>In addition, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 is able to abolish transcriptional stimulation whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="205">
                    <text>In addition, further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 will abolish transcriptional stimulation whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="206">
                    <text>In addition, the deletion of yhiE abolished acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="207">
                    <text>In addition, the deletion of yhiE abolishes acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="208">
                    <text>In addition, the deletion of yhiE can abolish acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="209">
                    <text>In addition, the deletion of yhiE has abolished acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="210">
                    <text>In addition, the deletion of yhiE is able to abolish acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="211">
                    <text>In addition, the deletion of yhiE will abolish acid resistance whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="212">
                    <text>In addition, the mutations abolished the A/T-rich element whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="213">
                    <text>In addition, the mutations abolishes the A/T-rich element whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="214">
                    <text>In addition, the mutations can abolish the A/T-rich element whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="215">
                    <text>In addition, the mutations has abolished the A/T-rich element whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="216">
                    <text>In addition, the mutations is able to abolish the A/T-rich element whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="217">
                    <text>In addition, the mutations will abolish the A/T-rich element whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="218">
                    <text>In addition, this complete removal of FabD from the crude FAS abolished its BCFA biosynthesis whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="219">
                    <text>In addition, this complete removal of FabD from the crude FAS abolishes its BCFA biosynthesis whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="220">
                    <text>In addition, this complete removal of FabD from the crude FAS can abolish its BCFA biosynthesis whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="221">
                    <text>In addition, this complete removal of FabD from the crude FAS has abolished its BCFA biosynthesis whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="222">
                    <text>In addition, this complete removal of FabD from the crude FAS is able to abolish its BCFA biosynthesis whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="223">
                    <text>In addition, this complete removal of FabD from the crude FAS will abolish its BCFA biosynthesis whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="224">
                    <text>In contrast, Alp activity is abolished by Insertions, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="225">
                    <text>In contrast, Alp activity was abolished by Insertions, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="226">
                    <text>In contrast, HA and curli production by strain chi7122 is abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="227">
                    <text>In contrast, HA and curli production by strain chi7122 is abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="228">
                    <text>In contrast, HA and curli production by strain chi7122 was abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="229">
                    <text>In contrast, HA and curli production by strain chi7122 was abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="230">
                    <text>In contrast, Insertions abolished Alp activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="231">
                    <text>In contrast, Insertions abolishes Alp activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="232">
                    <text>In contrast, Insertions can abolish Alp activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="233">
                    <text>In contrast, Linomide and antibody-targeted superantigen therapy abolished formation of liver metastases in mice, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="234">
                    <text>In contrast, Linomide and antibody-targeted superantigen therapy abolishes formation of liver metastases in mice, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="235">
                    <text>In contrast, Linomide and antibody-targeted superantigen therapy can abolish formation of liver metastases in mice, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="236">
                    <text>In contrast, Mutation of the proximal GATA element in the context of the 700 or the 135 bp abolished synergy, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="237">
                    <text>In contrast, Mutation of the proximal GATA element in the context of the 700 or the 135 bp abolishes synergy, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="238">
                    <text>In contrast, Mutation of the proximal GATA element in the context of the 700 or the 135 bp can abolish synergy, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="239">
                    <text>In contrast, Mutations in the fhlA gene abolished production of the hydrogenase activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="240">
                    <text>In contrast, Mutations in the fhlA gene abolishes production of the hydrogenase activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="241">
                    <text>In contrast, Mutations in the fhlA gene can abolish production of the hydrogenase activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="242">
                    <text>In contrast, This acid resistance abolished deletion of ydeP, ydeO, or yhiE, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="243">
                    <text>In contrast, This acid resistance abolishes deletion of ydeP, ydeO, or yhiE, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="244">
                    <text>In contrast, This acid resistance can abolish deletion of ydeP, ydeO, or yhiE, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="245">
                    <text>In contrast, This acid resistance is abolished by deletion of ydeP, ydeO, or yhiE, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="246">
                    <text>In contrast, This acid resistance was abolished by deletion of ydeP, ydeO, or yhiE, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="247">
                    <text>In contrast, acid resistance is abolished by the deletion of yhiE, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="248">
                    <text>In contrast, acid resistance was abolished by the deletion of yhiE, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="249">
                    <text>In contrast, deletion of the distal tor box (box1) abolished torC induction, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="250">
                    <text>In contrast, deletion of the distal tor box (box1) abolishes torC induction, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="251">
                    <text>In contrast, deletion of the distal tor box (box1) can abolish torC induction, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="252">
                    <text>In contrast, deletion of ydeP, ydeO, or yhiE abolished This acid resistance, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="253">
                    <text>In contrast, deletion of ydeP, ydeO, or yhiE abolishes This acid resistance, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="254">
                    <text>In contrast, deletion of ydeP, ydeO, or yhiE can abolish This acid resistance, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="255">
                    <text>In contrast, deletion of ydeP, ydeO, or yhiE is abolished by This acid resistance, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="256">
                    <text>In contrast, deletion of ydeP, ydeO, or yhiE was abolished by This acid resistance, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="257">
                    <text>In contrast, disruption of rpoS, mlrA or csgA, and the curli subunit gene abolished HA and curli production by strain chi7122, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="258">
                    <text>In contrast, disruption of rpoS, mlrA or csgA, and the curli subunit gene abolishes HA and curli production by strain chi7122, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="259">
                    <text>In contrast, disruption of rpoS, mlrA or csgA, and the curli subunit gene can abolish HA and curli production by strain chi7122, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="260">
                    <text>In contrast, disruption of rpoS, mlrA or csgA, the curli subunit gene abolished HA and curli production by strain chi7122, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="261">
                    <text>In contrast, disruption of rpoS, mlrA or csgA, the curli subunit gene abolishes HA and curli production by strain chi7122, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="262">
                    <text>In contrast, disruption of rpoS, mlrA or csgA, the curli subunit gene can abolish HA and curli production by strain chi7122, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="263">
                    <text>In contrast, formation of liver metastases in mice is abolished by Linomide and antibody-targeted superantigen therapy, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="264">
                    <text>In contrast, formation of liver metastases in mice was abolished by Linomide and antibody-targeted superantigen therapy, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="265">
                    <text>In contrast, its BCFA biosynthesis is abolished by this complete removal of FabD from the crude FAS, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="266">
                    <text>In contrast, its BCFA biosynthesis was abolished by this complete removal of FabD from the crude FAS, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="267">
                    <text>In contrast, production of the hydrogenase activity is abolished by Mutations in the fhlA gene, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="268">
                    <text>In contrast, production of the hydrogenase activity was abolished by Mutations in the fhlA gene, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="269">
                    <text>In contrast, synergy is abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="270">
                    <text>In contrast, synergy was abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="271">
                    <text>In contrast, the A/T-rich element is abolished by the mutations, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="272">
                    <text>In contrast, the A/T-rich element was abolished by the mutations, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="273">
                    <text>In contrast, the deletion of yhiE abolished acid resistance, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="274">
                    <text>In contrast, the deletion of yhiE abolishes acid resistance, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="275">
                    <text>In contrast, the deletion of yhiE can abolish acid resistance, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="276">
                    <text>In contrast, the mutations abolished the A/T-rich element, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="277">
                    <text>In contrast, the mutations abolishes the A/T-rich element, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="278">
                    <text>In contrast, the mutations can abolish the A/T-rich element, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="279">
                    <text>In contrast, this complete removal of FabD from the crude FAS abolished its BCFA biosynthesis, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="280">
                    <text>In contrast, this complete removal of FabD from the crude FAS abolishes its BCFA biosynthesis, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="281">
                    <text>In contrast, this complete removal of FabD from the crude FAS can abolish its BCFA biosynthesis, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="282">
                    <text>In contrast, torC induction is abolished by deletion of the distal tor box (box1), whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="283">
                    <text>In contrast, torC induction was abolished by deletion of the distal tor box (box1), whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="284">
                    <text>Insertions abolished Alp activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="285">
                    <text>Insertions abolishes Alp activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="286">
                    <text>Insertions also abolish Alp activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="287">
                    <text>Insertions also abolished Alp activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="288">
                    <text>Insertions can abolish Alp activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="289">
                    <text>Insertions can completely abolishes Alp activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="290">
                    <text>Insertions has also abolished Alp activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="291">
                    <text>Insertions promoter completely abolished Alp activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="292">
                    <text>Insertions promoter completely abolishes Alp activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="293">
                    <text>Insertions was abolished by Alp activity, which was induced by EvgA overexpression.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="294">
                    <text>Insertions will abolish Alp activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="295">
                    <text>Insertions will also abolish Alp activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="296">
                    <text>Linomide and antibody-targeted superantigen therapy also abolish formation of liver metastases in mice associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="297">
                    <text>Linomide and antibody-targeted superantigen therapy also abolished formation of liver metastases in mice associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="298">
                    <text>Linomide and antibody-targeted superantigen therapy being able to abolish formation of liver metastases in mice interrupt this open reading frame.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="299">
                    <text>Linomide and antibody-targeted superantigen therapy can completely abolishes formation of liver metastases in mice, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="300">
                    <text>Linomide and antibody-targeted superantigen therapy has also abolished formation of liver metastases in mice associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="301">
                    <text>Linomide and antibody-targeted superantigen therapy promoter completely abolished formation of liver metastases in mice, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="302">
                    <text>Linomide and antibody-targeted superantigen therapy promoter completely abolishes formation of liver metastases in mice, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="303">
                    <text>Linomide and antibody-targeted superantigen therapy was abolished by formation of liver metastases in mice, which was induced by EvgA overexpression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="304">
                    <text>Linomide and antibody-targeted superantigen therapy which abolish formation of liver metastases in mice interrupt this open reading frame.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="305">
                    <text>Linomide and antibody-targeted superantigen therapy which abolished formation of liver metastases in mice interrupt this open reading frame.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="306">
                    <text>Linomide and antibody-targeted superantigen therapy which has abolished formation of liver metastases in mice interrupt this open reading frame.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="307">
                    <text>Linomide and antibody-targeted superantigen therapy will also abolish formation of liver metastases in mice associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="308">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp abolished synergy.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="309">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp abolishes synergy.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="310">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp also abolish synergy associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="311">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp also abolished synergy associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="312">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp being able to abolish synergy interrupt this open reading frame.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="313">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp can abolish synergy.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="314">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp has also abolished synergy associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="315">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp was abolished by synergy, which was induced by EvgA overexpression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="316">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp which abolish synergy interrupt this open reading frame.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="317">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp which abolished synergy interrupt this open reading frame.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="318">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp which has abolished synergy interrupt this open reading frame.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="319">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp will abolish synergy.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="320">
                    <text>Mutation of the proximal GATA element in the context of the 700 or the 135 bp will also abolish synergy associated with formate hydrogenlyase activity.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="321">
                    <text>Mutations in the fhlA gene abolished production of the hydrogenase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="322">
                    <text>Mutations in the fhlA gene abolishes production of the hydrogenase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="323">
                    <text>Mutations in the fhlA gene being able to abolish production of the hydrogenase activity interrupt this open reading frame.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="324">
                    <text>Mutations in the fhlA gene can abolish production of the hydrogenase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="325">
                    <text>Mutations in the fhlA gene can completely abolishes production of the hydrogenase activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="326">
                    <text>Mutations in the fhlA gene promoter completely abolished production of the hydrogenase activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="327">
                    <text>Mutations in the fhlA gene promoter completely abolishes production of the hydrogenase activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="328">
                    <text>Mutations in the fhlA gene was abolished by production of the hydrogenase activity, which was induced by EvgA overexpression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="329">
                    <text>Mutations in the fhlA gene which abolish production of the hydrogenase activity interrupt this open reading frame.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="330">
                    <text>Mutations in the fhlA gene which abolished production of the hydrogenase activity interrupt this open reading frame.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="331">
                    <text>Mutations in the fhlA gene which has abolished production of the hydrogenase activity interrupt this open reading frame.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="332">
                    <text>Mutations in the fhlA gene will abolish production of the hydrogenase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="333">
                    <text>The A/T-rich mut sequence indicates Insertions can abolish Alp activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="334">
                    <text>The A/T-rich mut sequence indicates Insertions introduced to abolish Alp activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="335">
                    <text>The A/T-rich mut sequence indicates Linomide and antibody-targeted superantigen therapy can abolish formation of liver metastases in mice.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="336">
                    <text>The A/T-rich mut sequence indicates Linomide and antibody-targeted superantigen therapy introduced to abolish formation of liver metastases in mice.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="337">
                    <text>The A/T-rich mut sequence indicates Mutation of the proximal GATA element in the context of the 700 or the 135 bp can abolish synergy.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="338">
                    <text>The A/T-rich mut sequence indicates Mutation of the proximal GATA element in the context of the 700 or the 135 bp introduced to abolish synergy.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="339">
                    <text>The A/T-rich mut sequence indicates Mutations in the fhlA gene can abolish production of the hydrogenase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="340">
                    <text>The A/T-rich mut sequence indicates Mutations in the fhlA gene introduced to abolish production of the hydrogenase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="341">
                    <text>The A/T-rich mut sequence indicates This acid resistance can abolish deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="342">
                    <text>The A/T-rich mut sequence indicates This acid resistance introduced to abolish deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="343">
                    <text>The A/T-rich mut sequence indicates deletion of the distal tor box (box1) can abolish torC induction.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="344">
                    <text>The A/T-rich mut sequence indicates deletion of the distal tor box (box1) introduced to abolish torC induction.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="345">
                    <text>The A/T-rich mut sequence indicates deletion of ydeP, ydeO, or yhiE can abolish This acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="346">
                    <text>The A/T-rich mut sequence indicates deletion of ydeP, ydeO, or yhiE introduced to abolish This acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="347">
                    <text>The A/T-rich mut sequence indicates disruption of rpoS, mlrA or csgA, and the curli subunit gene can abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="348">
                    <text>The A/T-rich mut sequence indicates disruption of rpoS, mlrA or csgA, and the curli subunit gene introduced to abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="349">
                    <text>The A/T-rich mut sequence indicates disruption of rpoS, mlrA or csgA, the curli subunit gene can abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="350">
                    <text>The A/T-rich mut sequence indicates disruption of rpoS, mlrA or csgA, the curli subunit gene introduced to abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="351">
                    <text>The A/T-rich mut sequence indicates further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 can abolish transcriptional stimulation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="352">
                    <text>The A/T-rich mut sequence indicates further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 introduced to abolish transcriptional stimulation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="353">
                    <text>The A/T-rich mut sequence indicates that Alp activity is abolished by Insertions.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="354">
                    <text>The A/T-rich mut sequence indicates that Alp activity was abolished by Insertions.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="355">
                    <text>The A/T-rich mut sequence indicates that HA and curli production by strain chi7122 is abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="356">
                    <text>The A/T-rich mut sequence indicates that HA and curli production by strain chi7122 is abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="357">
                    <text>The A/T-rich mut sequence indicates that HA and curli production by strain chi7122 was abolished by disruption of rpoS, mlrA or csgA, and the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="358">
                    <text>The A/T-rich mut sequence indicates that HA and curli production by strain chi7122 was abolished by disruption of rpoS, mlrA or csgA, the curli subunit gene.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="359">
                    <text>The A/T-rich mut sequence indicates that Insertions abolish Alp activity.</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="360">
                    <text>The A/T-rich mut sequence indicates that Insertions abolished Alp activity.&#x09;</text>
                    <arg n="0">Insertions</arg>
                    <arg n="1">Alp activity</arg>
                </example>
                <example src="PERMUTATE" no="361">
                    <text>The A/T-rich mut sequence indicates that Linomide and antibody-targeted superantigen therapy abolish formation of liver metastases in mice.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="362">
                    <text>The A/T-rich mut sequence indicates that Linomide and antibody-targeted superantigen therapy abolished formation of liver metastases in mice.&#x09;</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="363">
                    <text>The A/T-rich mut sequence indicates that Mutation of the proximal GATA element in the context of the 700 or the 135 bp abolish synergy.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="364">
                    <text>The A/T-rich mut sequence indicates that Mutation of the proximal GATA element in the context of the 700 or the 135 bp abolished synergy.&#x09;</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="365">
                    <text>The A/T-rich mut sequence indicates that Mutations in the fhlA gene abolish production of the hydrogenase activity.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="366">
                    <text>The A/T-rich mut sequence indicates that Mutations in the fhlA gene abolished production of the hydrogenase activity.&#x09;</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="367">
                    <text>The A/T-rich mut sequence indicates that This acid resistance abolish deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="368">
                    <text>The A/T-rich mut sequence indicates that This acid resistance abolished deletion of ydeP, ydeO, or yhiE.&#x09;</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="369">
                    <text>The A/T-rich mut sequence indicates that This acid resistance is abolished by deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="370">
                    <text>The A/T-rich mut sequence indicates that This acid resistance was abolished by deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="371">
                    <text>The A/T-rich mut sequence indicates that acid resistance is abolished by the deletion of yhiE.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="372">
                    <text>The A/T-rich mut sequence indicates that acid resistance was abolished by the deletion of yhiE.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="373">
                    <text>The A/T-rich mut sequence indicates that deletion of the distal tor box (box1) abolish torC induction.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="374">
                    <text>The A/T-rich mut sequence indicates that deletion of the distal tor box (box1) abolished torC induction.&#x09;</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="375">
                    <text>The A/T-rich mut sequence indicates that deletion of ydeP, ydeO, or yhiE abolish This acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="376">
                    <text>The A/T-rich mut sequence indicates that deletion of ydeP, ydeO, or yhiE abolished This acid resistance.&#x09;</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="377">
                    <text>The A/T-rich mut sequence indicates that deletion of ydeP, ydeO, or yhiE is abolished by This acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="378">
                    <text>The A/T-rich mut sequence indicates that deletion of ydeP, ydeO, or yhiE was abolished by This acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="379">
                    <text>The A/T-rich mut sequence indicates that disruption of rpoS, mlrA or csgA, and the curli subunit gene abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="380">
                    <text>The A/T-rich mut sequence indicates that disruption of rpoS, mlrA or csgA, and the curli subunit gene abolished HA and curli production by strain chi7122.&#x09;</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="381">
                    <text>The A/T-rich mut sequence indicates that disruption of rpoS, mlrA or csgA, the curli subunit gene abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="382">
                    <text>The A/T-rich mut sequence indicates that disruption of rpoS, mlrA or csgA, the curli subunit gene abolished HA and curli production by strain chi7122.&#x09;</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="383">
                    <text>The A/T-rich mut sequence indicates that formation of liver metastases in mice is abolished by Linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="384">
                    <text>The A/T-rich mut sequence indicates that formation of liver metastases in mice was abolished by Linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="385">
                    <text>The A/T-rich mut sequence indicates that further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 abolish transcriptional stimulation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="386">
                    <text>The A/T-rich mut sequence indicates that further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 abolished transcriptional stimulation.&#x09;</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="387">
                    <text>The A/T-rich mut sequence indicates that its BCFA biosynthesis is abolished by this complete removal of FabD from the crude FAS.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="388">
                    <text>The A/T-rich mut sequence indicates that its BCFA biosynthesis was abolished by this complete removal of FabD from the crude FAS.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="389">
                    <text>The A/T-rich mut sequence indicates that production of the hydrogenase activity is abolished by Mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="390">
                    <text>The A/T-rich mut sequence indicates that production of the hydrogenase activity was abolished by Mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="391">
                    <text>The A/T-rich mut sequence indicates that synergy is abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="392">
                    <text>The A/T-rich mut sequence indicates that synergy was abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="393">
                    <text>The A/T-rich mut sequence indicates that the deletion of yhiE abolish acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="394">
                    <text>The A/T-rich mut sequence indicates that the deletion of yhiE abolished acid resistance.&#x09;</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="395">
                    <text>The A/T-rich mut sequence indicates that this complete removal of FabD from the crude FAS abolish its BCFA biosynthesis.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="396">
                    <text>The A/T-rich mut sequence indicates that this complete removal of FabD from the crude FAS abolished its BCFA biosynthesis.&#x09;</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="397">
                    <text>The A/T-rich mut sequence indicates that torC induction is abolished by deletion of the distal tor box (box1).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="398">
                    <text>The A/T-rich mut sequence indicates that torC induction was abolished by deletion of the distal tor box (box1).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="399">
                    <text>The A/T-rich mut sequence indicates that transcriptional stimulation is abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="400">
                    <text>The A/T-rich mut sequence indicates that transcriptional stimulation was abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="401">
                    <text>The A/T-rich mut sequence indicates the deletion of yhiE can abolish acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="402">
                    <text>The A/T-rich mut sequence indicates the deletion of yhiE introduced to abolish acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="403">
                    <text>The A/T-rich mut sequence indicates this complete removal of FabD from the crude FAS can abolish its BCFA biosynthesis.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="404">
                    <text>The A/T-rich mut sequence indicates this complete removal of FabD from the crude FAS introduced to abolish its BCFA biosynthesis.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="405">
                    <text>The deletion of ydeP, ydeO, or yhiE which was induced by EvgA overexpression abolish this acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="406">
                    <text>The deletion of ydeP, ydeO, or yhiE which was induced by EvgA overexpression abolished this acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="407">
                    <text>This acid resistance abolished deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="408">
                    <text>This acid resistance abolishes deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="409">
                    <text>This acid resistance also abolish deletion of ydeP, ydeO, or yhiE associated with formate hydrogenlyase activity.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="410">
                    <text>This acid resistance also abolished deletion of ydeP, ydeO, or yhiE associated with formate hydrogenlyase activity.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="411">
                    <text>This acid resistance are abolished by deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="412">
                    <text>This acid resistance being able to abolish deletion of ydeP, ydeO, or yhiE interrupt this open reading frame.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="413">
                    <text>This acid resistance can abolish deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="414">
                    <text>This acid resistance can be abolished by deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="415">
                    <text>This acid resistance can completely abolishes deletion of ydeP, ydeO, or yhiE, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="416">
                    <text>This acid resistance has also abolished deletion of ydeP, ydeO, or yhiE associated with formate hydrogenlyase activity.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="417">
                    <text>This acid resistance has been abolished by deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="418">
                    <text>This acid resistance is abolished by deletion of ydeP, ydeO, or yhiE which interrupt this open reading frame.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="419">
                    <text>This acid resistance promoter completely abolished deletion of ydeP, ydeO, or yhiE, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="420">
                    <text>This acid resistance promoter completely abolishes deletion of ydeP, ydeO, or yhiE, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="421">
                    <text>This acid resistance was abolished by deletion of ydeP, ydeO, or yhiE which interrupt this open reading frame.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="422">
                    <text>This acid resistance was abolished by deletion of ydeP, ydeO, or yhiE, which was induced by EvgA overexpression.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="423">
                    <text>This acid resistance were abolished by deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="424">
                    <text>This acid resistance which abolish deletion of ydeP, ydeO, or yhiE interrupt this open reading frame.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="425">
                    <text>This acid resistance which abolished deletion of ydeP, ydeO, or yhiE interrupt this open reading frame.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="426">
                    <text>This acid resistance which has abolished deletion of ydeP, ydeO, or yhiE interrupt this open reading frame.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="427">
                    <text>This acid resistance will abolish deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="428">
                    <text>This acid resistance will also abolish deletion of ydeP, ydeO, or yhiE associated with formate hydrogenlyase activity.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="429">
                    <text>This acid resistance will be abolished by deletion of ydeP, ydeO, or yhiE.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="430">
                    <text>acid resistance are abolished by the deletion of yhiE.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="431">
                    <text>acid resistance can be abolished by the deletion of yhiE.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="432">
                    <text>acid resistance has been abolished by the deletion of yhiE, which was induced by EvgA overexpression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="433">
                    <text>acid resistance has been abolished by the deletion of yhiE.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="434">
                    <text>acid resistance is abolished by the deletion of yhiE which interrupt this open reading frame.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="435">
                    <text>acid resistance is abolished by the deletion of yhiE, which was induced by EvgA overexpression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="436">
                    <text>acid resistance was abolished by the deletion of yhiE which interrupt this open reading frame.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="437">
                    <text>acid resistance were abolished by the deletion of yhiE.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="438">
                    <text>acid resistance will be abolished by the deletion of yhiE, which was induced by EvgA overexpression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="439">
                    <text>acid resistance will be abolished by the deletion of yhiE.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="440">
                    <text>deletion of the distal tor box (box1) abolished torC induction.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="441">
                    <text>deletion of the distal tor box (box1) abolishes torC induction.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="442">
                    <text>deletion of the distal tor box (box1) also abolish torC induction associated with formate hydrogenlyase activity.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="443">
                    <text>deletion of the distal tor box (box1) also abolished torC induction associated with formate hydrogenlyase activity.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="444">
                    <text>deletion of the distal tor box (box1) being able to abolish torC induction interrupt this open reading frame.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="445">
                    <text>deletion of the distal tor box (box1) can abolish torC induction.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="446">
                    <text>deletion of the distal tor box (box1) can completely abolishes torC induction, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="447">
                    <text>deletion of the distal tor box (box1) has also abolished torC induction associated with formate hydrogenlyase activity.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="448">
                    <text>deletion of the distal tor box (box1) promoter completely abolished torC induction, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="449">
                    <text>deletion of the distal tor box (box1) promoter completely abolishes torC induction, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="450">
                    <text>deletion of the distal tor box (box1) was abolished by torC induction, which was induced by EvgA overexpression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="451">
                    <text>deletion of the distal tor box (box1) which abolish torC induction interrupt this open reading frame.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="452">
                    <text>deletion of the distal tor box (box1) which abolished torC induction interrupt this open reading frame.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="453">
                    <text>deletion of the distal tor box (box1) which has abolished torC induction interrupt this open reading frame.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="454">
                    <text>deletion of the distal tor box (box1) will abolish torC induction.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="455">
                    <text>deletion of the distal tor box (box1) will also abolish torC induction associated with formate hydrogenlyase activity.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="456">
                    <text>deletion of ydeP, ydeO, or yhiE abolished This acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="457">
                    <text>deletion of ydeP, ydeO, or yhiE abolishes This acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="458">
                    <text>deletion of ydeP, ydeO, or yhiE also abolish This acid resistance associated with formate hydrogenlyase activity.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="459">
                    <text>deletion of ydeP, ydeO, or yhiE also abolished This acid resistance associated with formate hydrogenlyase activity.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="460">
                    <text>deletion of ydeP, ydeO, or yhiE are abolished by This acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="461">
                    <text>deletion of ydeP, ydeO, or yhiE being able to abolish This acid resistance interrupt this open reading frame.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="462">
                    <text>deletion of ydeP, ydeO, or yhiE can abolish This acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="463">
                    <text>deletion of ydeP, ydeO, or yhiE can be abolished by This acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="464">
                    <text>deletion of ydeP, ydeO, or yhiE can completely abolishes This acid resistance, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="465">
                    <text>deletion of ydeP, ydeO, or yhiE has also abolished This acid resistance associated with formate hydrogenlyase activity.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="466">
                    <text>deletion of ydeP, ydeO, or yhiE has been abolished by This acid resistance, which was induced by EvgA overexpression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="467">
                    <text>deletion of ydeP, ydeO, or yhiE has been abolished by This acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="468">
                    <text>deletion of ydeP, ydeO, or yhiE is abolished by This acid resistance which interrupt this open reading frame.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="469">
                    <text>deletion of ydeP, ydeO, or yhiE is abolished by This acid resistance, which was induced by EvgA overexpression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="470">
                    <text>deletion of ydeP, ydeO, or yhiE promoter completely abolished This acid resistance, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="471">
                    <text>deletion of ydeP, ydeO, or yhiE promoter completely abolishes This acid resistance, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="472">
                    <text>deletion of ydeP, ydeO, or yhiE was abolished by This acid resistance which interrupt this open reading frame.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="473">
                    <text>deletion of ydeP, ydeO, or yhiE were abolished by This acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="474">
                    <text>deletion of ydeP, ydeO, or yhiE which abolish This acid resistance interrupt this open reading frame.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="475">
                    <text>deletion of ydeP, ydeO, or yhiE which abolished This acid resistance interrupt this open reading frame.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="476">
                    <text>deletion of ydeP, ydeO, or yhiE which has abolished This acid resistance interrupt this open reading frame.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="477">
                    <text>deletion of ydeP, ydeO, or yhiE will abolish This acid resistance.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="478">
                    <text>deletion of ydeP, ydeO, or yhiE will also abolish This acid resistance associated with formate hydrogenlyase activity.</text>
                    <arg n="0">deletion of ydeP, ydeO, or yhiE</arg>
                    <arg n="1">This acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="479">
                    <text>deletion of ydeP, ydeO, or yhiE will be abolished by This acid resistance, which was induced by EvgA overexpression.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="480">
                    <text>deletion of ydeP, ydeO, or yhiE will be abolished by This acid resistance.</text>
                    <arg n="0">This acid resistance</arg>
                    <arg n="1">deletion of ydeP, ydeO, or yhiE</arg>
                </example>
                <example src="PERMUTATE" no="481">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene abolished HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="482">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene abolishes HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="483">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene also abolish HA and curli production by strain chi7122 associated with formate hydrogenlyase activity.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="484">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene also abolished HA and curli production by strain chi7122 associated with formate hydrogenlyase activity.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="485">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene being able to abolish HA and curli production by strain chi7122 interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="486">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene can abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="487">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene can completely abolishes HA and curli production by strain chi7122, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="488">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene has also abolished HA and curli production by strain chi7122 associated with formate hydrogenlyase activity.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="489">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene promoter completely abolished HA and curli production by strain chi7122, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="490">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene promoter completely abolishes HA and curli production by strain chi7122, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="491">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene was abolished by HA and curli production by strain chi7122, which was induced by EvgA overexpression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="492">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene which abolish HA and curli production by strain chi7122 interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="493">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene which abolished HA and curli production by strain chi7122 interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="494">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene which has abolished HA and curli production by strain chi7122 interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="495">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene will abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="496">
                    <text>disruption of rpoS, mlrA or csgA, and the curli subunit gene will also abolish HA and curli production by strain chi7122 associated with formate hydrogenlyase activity.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, and the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="497">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene abolished HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="498">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene abolishes HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="499">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene also abolish HA and curli production by strain chi7122 associated with formate hydrogenlyase activity.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="500">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene also abolished HA and curli production by strain chi7122 associated with formate hydrogenlyase activity.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="501">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene being able to abolish HA and curli production by strain chi7122 interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="502">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene can abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="503">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene can completely abolishes HA and curli production by strain chi7122, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="504">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene has also abolished HA and curli production by strain chi7122 associated with formate hydrogenlyase activity.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="505">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene promoter completely abolished HA and curli production by strain chi7122, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="506">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene promoter completely abolishes HA and curli production by strain chi7122, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="507">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene was abolished by HA and curli production by strain chi7122, which was induced by EvgA overexpression.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="508">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene which abolish HA and curli production by strain chi7122 interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="509">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene which abolished HA and curli production by strain chi7122 interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="510">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene which has abolished HA and curli production by strain chi7122 interrupt this open reading frame.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="511">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene will abolish HA and curli production by strain chi7122.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="512">
                    <text>disruption of rpoS, mlrA or csgA, the curli subunit gene will also abolish HA and curli production by strain chi7122 associated with formate hydrogenlyase activity.</text>
                    <arg n="0">disruption of rpoS, mlrA or csgA, the curli subunit gene</arg>
                    <arg n="1">HA and curli production by strain chi7122</arg>
                </example>
                <example src="PERMUTATE" no="513">
                    <text>formation of liver metastases in mice are abolished by Linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="514">
                    <text>formation of liver metastases in mice can be abolished by Linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="515">
                    <text>formation of liver metastases in mice has been abolished by Linomide and antibody-targeted superantigen therapy, which was induced by EvgA overexpression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="516">
                    <text>formation of liver metastases in mice has been abolished by Linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="517">
                    <text>formation of liver metastases in mice is abolished by Linomide and antibody-targeted superantigen therapy which interrupt this open reading frame.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="518">
                    <text>formation of liver metastases in mice is abolished by Linomide and antibody-targeted superantigen therapy, which was induced by EvgA overexpression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="519">
                    <text>formation of liver metastases in mice was abolished by Linomide and antibody-targeted superantigen therapy which interrupt this open reading frame.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="520">
                    <text>formation of liver metastases in mice were abolished by Linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="521">
                    <text>formation of liver metastases in mice will be abolished by Linomide and antibody-targeted superantigen therapy, which was induced by EvgA overexpression.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="522">
                    <text>formation of liver metastases in mice will be abolished by Linomide and antibody-targeted superantigen therapy.</text>
                    <arg n="0">Linomide and antibody-targeted superantigen therapy</arg>
                    <arg n="1">formation of liver metastases in mice</arg>
                </example>
                <example src="PERMUTATE" no="523">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 abolished transcriptional stimulation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="524">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 abolishes transcriptional stimulation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="525">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 also abolish transcriptional stimulation associated with formate hydrogenlyase activity.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="526">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 also abolished transcriptional stimulation associated with formate hydrogenlyase activity.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="527">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 being able to abolish transcriptional stimulation interrupt this open reading frame.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="528">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 can abolish transcriptional stimulation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="529">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 can completely abolishes transcriptional stimulation, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="530">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 has also abolished transcriptional stimulation associated with formate hydrogenlyase activity.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="531">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 promoter completely abolished transcriptional stimulation, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="532">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 promoter completely abolishes transcriptional stimulation, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="533">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 was abolished by transcriptional stimulation, which was induced by EvgA overexpression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="534">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 which abolish transcriptional stimulation interrupt this open reading frame.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="535">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 which abolished transcriptional stimulation interrupt this open reading frame.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="536">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 which has abolished transcriptional stimulation interrupt this open reading frame.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="537">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 will abolish transcriptional stimulation.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="538">
                    <text>further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 will also abolish transcriptional stimulation associated with formate hydrogenlyase activity.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="539">
                    <text>its BCFA biosynthesis are abolished by this complete removal of FabD from the crude FAS.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="540">
                    <text>its BCFA biosynthesis can be abolished by this complete removal of FabD from the crude FAS.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="541">
                    <text>its BCFA biosynthesis has been abolished by this complete removal of FabD from the crude FAS, which was induced by EvgA overexpression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="542">
                    <text>its BCFA biosynthesis has been abolished by this complete removal of FabD from the crude FAS.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="543">
                    <text>its BCFA biosynthesis is abolished by this complete removal of FabD from the crude FAS which interrupt this open reading frame.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="544">
                    <text>its BCFA biosynthesis is abolished by this complete removal of FabD from the crude FAS, which was induced by EvgA overexpression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="545">
                    <text>its BCFA biosynthesis was abolished by this complete removal of FabD from the crude FAS which interrupt this open reading frame.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="546">
                    <text>its BCFA biosynthesis were abolished by this complete removal of FabD from the crude FAS.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="547">
                    <text>its BCFA biosynthesis will be abolished by this complete removal of FabD from the crude FAS, which was induced by EvgA overexpression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="548">
                    <text>its BCFA biosynthesis will be abolished by this complete removal of FabD from the crude FAS.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="549">
                    <text>production of the hydrogenase activity are abolished by Mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="550">
                    <text>production of the hydrogenase activity can be abolished by Mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="551">
                    <text>production of the hydrogenase activity has been abolished by Mutations in the fhlA gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="552">
                    <text>production of the hydrogenase activity has been abolished by Mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="553">
                    <text>production of the hydrogenase activity is abolished by Mutations in the fhlA gene which interrupt this open reading frame.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="554">
                    <text>production of the hydrogenase activity is abolished by Mutations in the fhlA gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="555">
                    <text>production of the hydrogenase activity was abolished by Mutations in the fhlA gene which interrupt this open reading frame.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="556">
                    <text>production of the hydrogenase activity were abolished by Mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="557">
                    <text>production of the hydrogenase activity will be abolished by Mutations in the fhlA gene, which was induced by EvgA overexpression.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="558">
                    <text>production of the hydrogenase activity will be abolished by Mutations in the fhlA gene.</text>
                    <arg n="0">Mutations in the fhlA gene</arg>
                    <arg n="1">production of the hydrogenase activity</arg>
                </example>
                <example src="PERMUTATE" no="559">
                    <text>synergy are abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="560">
                    <text>synergy can be abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="561">
                    <text>synergy has been abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, which was induced by EvgA overexpression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="562">
                    <text>synergy has been abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="563">
                    <text>synergy is abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp which interrupt this open reading frame.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="564">
                    <text>synergy is abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, which was induced by EvgA overexpression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="565">
                    <text>synergy was abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp which interrupt this open reading frame.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="566">
                    <text>synergy were abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="567">
                    <text>synergy will be abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp, which was induced by EvgA overexpression.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="568">
                    <text>synergy will be abolished by Mutation of the proximal GATA element in the context of the 700 or the 135 bp.</text>
                    <arg n="0">Mutation of the proximal GATA element in the context of the 700 or the 135 bp</arg>
                    <arg n="1">synergy</arg>
                </example>
                <example src="PERMUTATE" no="569">
                    <text>the A/T-rich element are abolished by the mutations.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="570">
                    <text>the A/T-rich element can be abolished by the mutations.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="571">
                    <text>the A/T-rich element has been abolished by the mutations, which was induced by EvgA overexpression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="572">
                    <text>the A/T-rich element has been abolished by the mutations.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="573">
                    <text>the A/T-rich element is abolished by the mutations which interrupt this open reading frame.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="574">
                    <text>the A/T-rich element is abolished by the mutations, which was induced by EvgA overexpression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="575">
                    <text>the A/T-rich element was abolished by the mutations which interrupt this open reading frame.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="576">
                    <text>the A/T-rich element were abolished by the mutations.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="577">
                    <text>the A/T-rich element will be abolished by the mutations, which was induced by EvgA overexpression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="578">
                    <text>the A/T-rich element will be abolished by the mutations.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="579">
                    <text>the deletion of yhiE abolished acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="580">
                    <text>the deletion of yhiE abolishes acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="581">
                    <text>the deletion of yhiE also abolish acid resistance associated with formate hydrogenlyase activity.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="582">
                    <text>the deletion of yhiE also abolished acid resistance associated with formate hydrogenlyase activity.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="583">
                    <text>the deletion of yhiE being able to abolish acid resistance interrupt this open reading frame.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="584">
                    <text>the deletion of yhiE can abolish acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="585">
                    <text>the deletion of yhiE can completely abolishes acid resistance, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="586">
                    <text>the deletion of yhiE has also abolished acid resistance associated with formate hydrogenlyase activity.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="587">
                    <text>the deletion of yhiE promoter completely abolished acid resistance, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="588">
                    <text>the deletion of yhiE promoter completely abolishes acid resistance, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="589">
                    <text>the deletion of yhiE was abolished by acid resistance, which was induced by EvgA overexpression.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="590">
                    <text>the deletion of yhiE which abolish acid resistance interrupt this open reading frame.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="591">
                    <text>the deletion of yhiE which abolished acid resistance interrupt this open reading frame.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="592">
                    <text>the deletion of yhiE which has abolished acid resistance interrupt this open reading frame.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="593">
                    <text>the deletion of yhiE will abolish acid resistance.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="594">
                    <text>the deletion of yhiE will also abolish acid resistance associated with formate hydrogenlyase activity.</text>
                    <arg n="0">the deletion of yhiE</arg>
                    <arg n="1">acid resistance</arg>
                </example>
                <example src="PERMUTATE" no="595">
                    <text>the mutations abolished the A/T-rich element.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="596">
                    <text>the mutations abolishes the A/T-rich element.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="597">
                    <text>the mutations also abolish the A/T-rich element associated with formate hydrogenlyase activity.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="598">
                    <text>the mutations also abolished the A/T-rich element associated with formate hydrogenlyase activity.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="599">
                    <text>the mutations being able to abolish the A/T-rich element interrupt this open reading frame.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="600">
                    <text>the mutations can abolish the A/T-rich element.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="601">
                    <text>the mutations can completely abolishes the A/T-rich element, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="602">
                    <text>the mutations has also abolished the A/T-rich element associated with formate hydrogenlyase activity.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="603">
                    <text>the mutations promoter completely abolished the A/T-rich element, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="604">
                    <text>the mutations promoter completely abolishes the A/T-rich element, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="605">
                    <text>the mutations was abolished by the A/T-rich element, which was induced by EvgA overexpression.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="606">
                    <text>the mutations which abolish the A/T-rich element interrupt this open reading frame.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="607">
                    <text>the mutations which abolished the A/T-rich element interrupt this open reading frame.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="608">
                    <text>the mutations which has abolished the A/T-rich element interrupt this open reading frame.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="609">
                    <text>the mutations will abolish the A/T-rich element.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="610">
                    <text>the mutations will also abolish the A/T-rich element associated with formate hydrogenlyase activity.</text>
                    <arg n="0">the mutations</arg>
                    <arg n="1">the A/T-rich element</arg>
                </example>
                <example src="PERMUTATE" no="611">
                    <text>this complete removal of FabD from the crude FAS abolished its BCFA biosynthesis.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="612">
                    <text>this complete removal of FabD from the crude FAS abolishes its BCFA biosynthesis.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="613">
                    <text>this complete removal of FabD from the crude FAS also abolish its BCFA biosynthesis associated with formate hydrogenlyase activity.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="614">
                    <text>this complete removal of FabD from the crude FAS also abolished its BCFA biosynthesis associated with formate hydrogenlyase activity.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="615">
                    <text>this complete removal of FabD from the crude FAS being able to abolish its BCFA biosynthesis interrupt this open reading frame.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="616">
                    <text>this complete removal of FabD from the crude FAS can abolish its BCFA biosynthesis.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="617">
                    <text>this complete removal of FabD from the crude FAS can completely abolishes its BCFA biosynthesis, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="618">
                    <text>this complete removal of FabD from the crude FAS has also abolished its BCFA biosynthesis associated with formate hydrogenlyase activity.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="619">
                    <text>this complete removal of FabD from the crude FAS promoter completely abolished its BCFA biosynthesis, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="620">
                    <text>this complete removal of FabD from the crude FAS promoter completely abolishes its BCFA biosynthesis, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="621">
                    <text>this complete removal of FabD from the crude FAS was abolished by its BCFA biosynthesis, which was induced by EvgA overexpression.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="622">
                    <text>this complete removal of FabD from the crude FAS which abolish its BCFA biosynthesis interrupt this open reading frame.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="623">
                    <text>this complete removal of FabD from the crude FAS which abolished its BCFA biosynthesis interrupt this open reading frame.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="624">
                    <text>this complete removal of FabD from the crude FAS which has abolished its BCFA biosynthesis interrupt this open reading frame.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="625">
                    <text>this complete removal of FabD from the crude FAS will abolish its BCFA biosynthesis.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="626">
                    <text>this complete removal of FabD from the crude FAS will also abolish its BCFA biosynthesis associated with formate hydrogenlyase activity.</text>
                    <arg n="0">this complete removal of FabD from the crude FAS</arg>
                    <arg n="1">its BCFA biosynthesis</arg>
                </example>
                <example src="PERMUTATE" no="627">
                    <text>torC induction are abolished by deletion of the distal tor box (box1).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="628">
                    <text>torC induction can be abolished by deletion of the distal tor box (box1).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="629">
                    <text>torC induction has been abolished by deletion of the distal tor box (box1), which was induced by EvgA overexpression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="630">
                    <text>torC induction has been abolished by deletion of the distal tor box (box1).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="631">
                    <text>torC induction is abolished by deletion of the distal tor box (box1) which interrupt this open reading frame.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="632">
                    <text>torC induction is abolished by deletion of the distal tor box (box1), which was induced by EvgA overexpression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="633">
                    <text>torC induction was abolished by deletion of the distal tor box (box1) which interrupt this open reading frame.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="634">
                    <text>torC induction were abolished by deletion of the distal tor box (box1).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="635">
                    <text>torC induction will be abolished by deletion of the distal tor box (box1), which was induced by EvgA overexpression.</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="636">
                    <text>torC induction will be abolished by deletion of the distal tor box (box1).</text>
                    <arg n="0">deletion of the distal tor box (box1)</arg>
                    <arg n="1">torC induction</arg>
                </example>
                <example src="PERMUTATE" no="637">
                    <text>transcriptional stimulation are abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="638">
                    <text>transcriptional stimulation can be abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="639">
                    <text>transcriptional stimulation has been abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, which was induced by EvgA overexpression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="640">
                    <text>transcriptional stimulation has been abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="641">
                    <text>transcriptional stimulation is abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 which interrupt this open reading frame.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="642">
                    <text>transcriptional stimulation is abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, which was induced by EvgA overexpression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="643">
                    <text>transcriptional stimulation was abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9 which interrupt this open reading frame.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="644">
                    <text>transcriptional stimulation were abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="645">
                    <text>transcriptional stimulation will be abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9, which was induced by EvgA overexpression.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="PERMUTATE" no="646">
                    <text>transcriptional stimulation will be abolished by further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9.</text>
                    <arg n="0">further deletion of the C-terminal transactivation domain in the Pax5 mutants B8 and B9</arg>
                    <arg n="1">transcriptional stimulation</arg>
                </example>
                <example src="REPLACE" no="1">
                    <text>Furthermore, Groucho binding in stationary-phase cells has been completely abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="2">
                    <text>Furthermore, Groucho binding in stationary-phase cells is completely abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="3">
                    <text>Furthermore, RNA expression in stationary-phase cells has been completely abolished by one mutation, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="4">
                    <text>Furthermore, RNA expression in stationary-phase cells is completely abolished by one mutation, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="5">
                    <text>Furthermore, The cpx101 mutation completely abolished cpxA phosphatase activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="6">
                    <text>Furthermore, The cpx101 mutation completely abolishes cpxA phosphatase activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="7">
                    <text>Furthermore, The cpx101 mutation has completely abolished cpxA phosphatase activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="8">
                    <text>Furthermore, The cpx101 mutation will completely abolish cpxA phosphatase activity in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="9">
                    <text>Furthermore, This intronic mutation completely abolished normal LHX4 splicing in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="10">
                    <text>Furthermore, This intronic mutation completely abolishes normal LHX4 splicing in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="11">
                    <text>Furthermore, This intronic mutation has completely abolished normal LHX4 splicing in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="12">
                    <text>Furthermore, This intronic mutation will completely abolish normal LHX4 splicing in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="13">
                    <text>Furthermore, a G-to-A transition at the first nucleotide of intron 2 completely abolished normal splicing in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="14">
                    <text>Furthermore, a G-to-A transition at the first nucleotide of intron 2 completely abolishes normal splicing in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="15">
                    <text>Furthermore, a G-to-A transition at the first nucleotide of intron 2 has completely abolished normal splicing in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="16">
                    <text>Furthermore, a G-to-A transition at the first nucleotide of intron 2 will completely abolish normal splicing in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="17">
                    <text>Furthermore, co-administered DM completely abolished the CPP effect in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="18">
                    <text>Furthermore, co-administered DM completely abolishes the CPP effect in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="19">
                    <text>Furthermore, co-administered DM has completely abolished the CPP effect in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="20">
                    <text>Furthermore, co-administered DM will completely abolish the CPP effect in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="21">
                    <text>Furthermore, cpxA phosphatase activity in stationary-phase cells has been completely abolished by The cpx101 mutation, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="22">
                    <text>Furthermore, cpxA phosphatase activity in stationary-phase cells is completely abolished by The cpx101 mutation, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="23">
                    <text>Furthermore, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid completely abolished Groucho binding in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="24">
                    <text>Furthermore, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid completely abolishes Groucho binding in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="25">
                    <text>Furthermore, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid has completely abolished Groucho binding in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="26">
                    <text>Furthermore, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid will completely abolish Groucho binding in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="27">
                    <text>Furthermore, normal LHX4 splicing in stationary-phase cells has been completely abolished by This intronic mutation, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="28">
                    <text>Furthermore, normal LHX4 splicing in stationary-phase cells is completely abolished by This intronic mutation, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="29">
                    <text>Furthermore, normal splicing in stationary-phase cells has been completely abolished by a G-to-A transition at the first nucleotide of intron 2, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="30">
                    <text>Furthermore, normal splicing in stationary-phase cells is completely abolished by a G-to-A transition at the first nucleotide of intron 2, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="31">
                    <text>Furthermore, one mutation completely abolished RNA expression in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="32">
                    <text>Furthermore, one mutation completely abolishes RNA expression in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="33">
                    <text>Furthermore, one mutation has completely abolished RNA expression in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="34">
                    <text>Furthermore, one mutation will completely abolish RNA expression in stationary-phase cells, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="35">
                    <text>Furthermore, the CPP effect in stationary-phase cells has been completely abolished by co-administered DM, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="36">
                    <text>Furthermore, the CPP effect in stationary-phase cells is completely abolished by co-administered DM, suggesting that YhiE plays a critical role in stationary-phase acid resistance.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="37">
                    <text>Groucho binding are abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="38">
                    <text>Groucho binding can be abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="39">
                    <text>Groucho binding has been abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, which was induced by EvgA overexpression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="40">
                    <text>Groucho binding has been abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="41">
                    <text>Groucho binding is abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid which interrupt this open reading frame.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="42">
                    <text>Groucho binding is abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, which was induced by EvgA overexpression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="43">
                    <text>Groucho binding was abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid which interrupt this open reading frame.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="44">
                    <text>Groucho binding was abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, which was induced by EvgA overexpression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="45">
                    <text>Groucho binding were abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="46">
                    <text>Groucho binding will be abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, which was induced by EvgA overexpression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="47">
                    <text>Groucho binding will be abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="48">
                    <text>However, Groucho binding is not abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="49">
                    <text>However, Groucho binding was not abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="50">
                    <text>However, RNA expression is not abolished by one mutation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="51">
                    <text>However, RNA expression was not abolished by one mutation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="52">
                    <text>However, The cpx101 mutation did not abolish cpxA phosphatase activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="53">
                    <text>However, The cpx101 mutation does not abolish cpxA phosphatase activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="54">
                    <text>However, The cpx101 mutation will not abolish cpxA phosphatase activity, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="55">
                    <text>However, This intronic mutation did not abolish normal LHX4 splicing, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="56">
                    <text>However, This intronic mutation does not abolish normal LHX4 splicing, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="57">
                    <text>However, This intronic mutation will not abolish normal LHX4 splicing, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="58">
                    <text>However, a G-to-A transition at the first nucleotide of intron 2 did not abolish normal splicing, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="59">
                    <text>However, a G-to-A transition at the first nucleotide of intron 2 does not abolish normal splicing, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="60">
                    <text>However, a G-to-A transition at the first nucleotide of intron 2 will not abolish normal splicing, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="61">
                    <text>However, co-administered DM did not abolish the CPP effect, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="62">
                    <text>However, co-administered DM does not abolish the CPP effect, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="63">
                    <text>However, co-administered DM will not abolish the CPP effect, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="64">
                    <text>However, cpxA phosphatase activity is not abolished by The cpx101 mutation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="65">
                    <text>However, cpxA phosphatase activity was not abolished by The cpx101 mutation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="66">
                    <text>However, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid did not abolish Groucho binding, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="67">
                    <text>However, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid does not abolish Groucho binding, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="68">
                    <text>However, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid will not abolish Groucho binding, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="69">
                    <text>However, normal LHX4 splicing is not abolished by This intronic mutation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="70">
                    <text>However, normal LHX4 splicing was not abolished by This intronic mutation, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="71">
                    <text>However, normal splicing is not abolished by a G-to-A transition at the first nucleotide of intron 2, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="72">
                    <text>However, normal splicing was not abolished by a G-to-A transition at the first nucleotide of intron 2, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="73">
                    <text>However, one mutation did not abolish RNA expression, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="74">
                    <text>However, one mutation does not abolish RNA expression, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="75">
                    <text>However, one mutation will not abolish RNA expression, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="76">
                    <text>However, the CPP effect is not abolished by co-administered DM, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="77">
                    <text>However, the CPP effect was not abolished by co-administered DM, but only reduced the level to 50-60% of the control level for acyl-CoA primer and to 80% for alpha-keto-beta-methylvalerate primer.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="78">
                    <text>In addition, The cpx101 mutation abolished cpxA phosphatase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="79">
                    <text>In addition, The cpx101 mutation abolishes cpxA phosphatase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="80">
                    <text>In addition, The cpx101 mutation can abolish cpxA phosphatase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="81">
                    <text>In addition, The cpx101 mutation has abolished cpxA phosphatase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="82">
                    <text>In addition, The cpx101 mutation is able to abolish cpxA phosphatase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="83">
                    <text>In addition, The cpx101 mutation will abolish cpxA phosphatase activity whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="84">
                    <text>In addition, This intronic mutation abolished normal LHX4 splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="85">
                    <text>In addition, This intronic mutation abolishes normal LHX4 splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="86">
                    <text>In addition, This intronic mutation can abolish normal LHX4 splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="87">
                    <text>In addition, This intronic mutation has abolished normal LHX4 splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="88">
                    <text>In addition, This intronic mutation is able to abolish normal LHX4 splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="89">
                    <text>In addition, This intronic mutation will abolish normal LHX4 splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="90">
                    <text>In addition, a G-to-A transition at the first nucleotide of intron 2 abolished normal splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="91">
                    <text>In addition, a G-to-A transition at the first nucleotide of intron 2 abolishes normal splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="92">
                    <text>In addition, a G-to-A transition at the first nucleotide of intron 2 can abolish normal splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="93">
                    <text>In addition, a G-to-A transition at the first nucleotide of intron 2 has abolished normal splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="94">
                    <text>In addition, a G-to-A transition at the first nucleotide of intron 2 is able to abolish normal splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="95">
                    <text>In addition, a G-to-A transition at the first nucleotide of intron 2 will abolish normal splicing whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="96">
                    <text>In addition, co-administered DM abolished the CPP effect whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="97">
                    <text>In addition, co-administered DM abolishes the CPP effect whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="98">
                    <text>In addition, co-administered DM can abolish the CPP effect whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="99">
                    <text>In addition, co-administered DM has abolished the CPP effect whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="100">
                    <text>In addition, co-administered DM is able to abolish the CPP effect whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="101">
                    <text>In addition, co-administered DM will abolish the CPP effect whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="102">
                    <text>In addition, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolished Groucho binding whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="103">
                    <text>In addition, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolishes Groucho binding whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="104">
                    <text>In addition, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid can abolish Groucho binding whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="105">
                    <text>In addition, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid has abolished Groucho binding whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="106">
                    <text>In addition, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid is able to abolish Groucho binding whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="107">
                    <text>In addition, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid will abolish Groucho binding whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="108">
                    <text>In addition, one mutation abolished RNA expression whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="109">
                    <text>In addition, one mutation abolishes RNA expression whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="110">
                    <text>In addition, one mutation can abolish RNA expression whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="111">
                    <text>In addition, one mutation has abolished RNA expression whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="112">
                    <text>In addition, one mutation is able to abolish RNA expression whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="113">
                    <text>In addition, one mutation will abolish RNA expression whereas the presence of a DNA fragment starting three bases upstream from box1 suffices for normal torC expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="114">
                    <text>In contrast, Groucho binding is abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="115">
                    <text>In contrast, Groucho binding was abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="116">
                    <text>In contrast, RNA expression is abolished by one mutation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="117">
                    <text>In contrast, RNA expression was abolished by one mutation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="118">
                    <text>In contrast, The cpx101 mutation abolished cpxA phosphatase activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="119">
                    <text>In contrast, The cpx101 mutation abolishes cpxA phosphatase activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="120">
                    <text>In contrast, The cpx101 mutation can abolish cpxA phosphatase activity, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="121">
                    <text>In contrast, This intronic mutation abolished normal LHX4 splicing, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="122">
                    <text>In contrast, This intronic mutation abolishes normal LHX4 splicing, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="123">
                    <text>In contrast, This intronic mutation can abolish normal LHX4 splicing, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="124">
                    <text>In contrast, a G-to-A transition at the first nucleotide of intron 2 abolished normal splicing, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="125">
                    <text>In contrast, a G-to-A transition at the first nucleotide of intron 2 abolishes normal splicing, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="126">
                    <text>In contrast, a G-to-A transition at the first nucleotide of intron 2 can abolish normal splicing, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="127">
                    <text>In contrast, co-administered DM abolished the CPP effect, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="128">
                    <text>In contrast, co-administered DM abolishes the CPP effect, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="129">
                    <text>In contrast, co-administered DM can abolish the CPP effect, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="130">
                    <text>In contrast, cpxA phosphatase activity is abolished by The cpx101 mutation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="131">
                    <text>In contrast, cpxA phosphatase activity was abolished by The cpx101 mutation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="132">
                    <text>In contrast, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolished Groucho binding, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="133">
                    <text>In contrast, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolishes Groucho binding, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="134">
                    <text>In contrast, mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid can abolish Groucho binding, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="135">
                    <text>In contrast, normal LHX4 splicing is abolished by This intronic mutation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="136">
                    <text>In contrast, normal LHX4 splicing was abolished by This intronic mutation, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="137">
                    <text>In contrast, normal splicing is abolished by a G-to-A transition at the first nucleotide of intron 2, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="138">
                    <text>In contrast, normal splicing was abolished by a G-to-A transition at the first nucleotide of intron 2, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="139">
                    <text>In contrast, one mutation abolished RNA expression, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="140">
                    <text>In contrast, one mutation abolishes RNA expression, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="141">
                    <text>In contrast, one mutation can abolish RNA expression, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="142">
                    <text>In contrast, the CPP effect is abolished by co-administered DM, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="143">
                    <text>In contrast, the CPP effect was abolished by co-administered DM, whereas internal deletion of the conserved octapeptide motif (OP) or the partial homeodomain (HD) of Pax5 did not have any effect (Figure 3B).</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="144">
                    <text>RNA expression are abolished by one mutation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="145">
                    <text>RNA expression can be abolished by one mutation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="146">
                    <text>RNA expression has been abolished by one mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="147">
                    <text>RNA expression has been abolished by one mutation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="148">
                    <text>RNA expression is abolished by one mutation which interrupt this open reading frame.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="149">
                    <text>RNA expression is abolished by one mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="150">
                    <text>RNA expression was abolished by one mutation which interrupt this open reading frame.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="151">
                    <text>RNA expression was abolished by one mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="152">
                    <text>RNA expression were abolished by one mutation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="153">
                    <text>RNA expression will be abolished by one mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="154">
                    <text>RNA expression will be abolished by one mutation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="155">
                    <text>The A/T-rich mut sequence indicates The cpx101 mutation can abolish cpxA phosphatase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="156">
                    <text>The A/T-rich mut sequence indicates The cpx101 mutation introduced to abolish cpxA phosphatase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="157">
                    <text>The A/T-rich mut sequence indicates This intronic mutation can abolish normal LHX4 splicing.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="158">
                    <text>The A/T-rich mut sequence indicates This intronic mutation introduced to abolish normal LHX4 splicing.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="159">
                    <text>The A/T-rich mut sequence indicates a G-to-A transition at the first nucleotide of intron 2 can abolish normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="160">
                    <text>The A/T-rich mut sequence indicates a G-to-A transition at the first nucleotide of intron 2 introduced to abolish normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="161">
                    <text>The A/T-rich mut sequence indicates co-administered DM can abolish the CPP effect.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="162">
                    <text>The A/T-rich mut sequence indicates co-administered DM introduced to abolish the CPP effect.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="163">
                    <text>The A/T-rich mut sequence indicates mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid can abolish Groucho binding.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="164">
                    <text>The A/T-rich mut sequence indicates mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid introduced to abolish Groucho binding.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="165">
                    <text>The A/T-rich mut sequence indicates one mutation can abolish RNA expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="166">
                    <text>The A/T-rich mut sequence indicates one mutation introduced to abolish RNA expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="167">
                    <text>The A/T-rich mut sequence indicates that Groucho binding is abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="168">
                    <text>The A/T-rich mut sequence indicates that Groucho binding was abolished by mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="169">
                    <text>The A/T-rich mut sequence indicates that RNA expression is abolished by one mutation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="170">
                    <text>The A/T-rich mut sequence indicates that RNA expression was abolished by one mutation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="171">
                    <text>The A/T-rich mut sequence indicates that The cpx101 mutation abolish cpxA phosphatase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="172">
                    <text>The A/T-rich mut sequence indicates that The cpx101 mutation abolished cpxA phosphatase activity.&#x09;</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="173">
                    <text>The A/T-rich mut sequence indicates that This intronic mutation abolish normal LHX4 splicing.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="174">
                    <text>The A/T-rich mut sequence indicates that This intronic mutation abolished normal LHX4 splicing.&#x09;</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="175">
                    <text>The A/T-rich mut sequence indicates that a G-to-A transition at the first nucleotide of intron 2 abolish normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="176">
                    <text>The A/T-rich mut sequence indicates that a G-to-A transition at the first nucleotide of intron 2 abolished normal splicing.&#x09;</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="177">
                    <text>The A/T-rich mut sequence indicates that co-administered DM abolish the CPP effect.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="178">
                    <text>The A/T-rich mut sequence indicates that co-administered DM abolished the CPP effect.&#x09;</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="179">
                    <text>The A/T-rich mut sequence indicates that cpxA phosphatase activity is abolished by The cpx101 mutation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="180">
                    <text>The A/T-rich mut sequence indicates that cpxA phosphatase activity was abolished by The cpx101 mutation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="181">
                    <text>The A/T-rich mut sequence indicates that mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolish Groucho binding.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="182">
                    <text>The A/T-rich mut sequence indicates that mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolished Groucho binding.&#x09;</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="183">
                    <text>The A/T-rich mut sequence indicates that normal LHX4 splicing is abolished by This intronic mutation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="184">
                    <text>The A/T-rich mut sequence indicates that normal LHX4 splicing was abolished by This intronic mutation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="185">
                    <text>The A/T-rich mut sequence indicates that normal splicing is abolished by a G-to-A transition at the first nucleotide of intron 2.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="186">
                    <text>The A/T-rich mut sequence indicates that normal splicing was abolished by a G-to-A transition at the first nucleotide of intron 2.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="187">
                    <text>The A/T-rich mut sequence indicates that one mutation abolish RNA expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="188">
                    <text>The A/T-rich mut sequence indicates that one mutation abolished RNA expression.&#x09;</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="189">
                    <text>The A/T-rich mut sequence indicates that the CPP effect is abolished by co-administered DM.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="190">
                    <text>The A/T-rich mut sequence indicates that the CPP effect was abolished by co-administered DM.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="191">
                    <text>The cpx101 mutation abolished cpxA phosphatase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="192">
                    <text>The cpx101 mutation abolishes cpxA phosphatase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="193">
                    <text>The cpx101 mutation also abolish cpxA phosphatase activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="194">
                    <text>The cpx101 mutation also abolished cpxA phosphatase activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="195">
                    <text>The cpx101 mutation being able to abolish cpxA phosphatase activity interrupt this open reading frame.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="196">
                    <text>The cpx101 mutation can abolish cpxA phosphatase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="197">
                    <text>The cpx101 mutation can completely abolishes cpxA phosphatase activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="198">
                    <text>The cpx101 mutation has also abolished cpxA phosphatase activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="199">
                    <text>The cpx101 mutation promoter completely abolished cpxA phosphatase activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="200">
                    <text>The cpx101 mutation promoter completely abolishes cpxA phosphatase activity, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="201">
                    <text>The cpx101 mutation was abolished by cpxA phosphatase activity, which was induced by EvgA overexpression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="202">
                    <text>The cpx101 mutation which abolish cpxA phosphatase activity interrupt this open reading frame.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="203">
                    <text>The cpx101 mutation which abolished cpxA phosphatase activity interrupt this open reading frame.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="204">
                    <text>The cpx101 mutation which has abolished cpxA phosphatase activity interrupt this open reading frame.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="205">
                    <text>The cpx101 mutation will abolish cpxA phosphatase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="206">
                    <text>The cpx101 mutation will also abolish cpxA phosphatase activity associated with formate hydrogenlyase activity.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="207">
                    <text>This intronic mutation abolished normal LHX4 splicing.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="208">
                    <text>This intronic mutation abolishes normal LHX4 splicing.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="209">
                    <text>This intronic mutation also abolish normal LHX4 splicing associated with formate hydrogenlyase activity.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="210">
                    <text>This intronic mutation also abolished normal LHX4 splicing associated with formate hydrogenlyase activity.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="211">
                    <text>This intronic mutation being able to abolish normal LHX4 splicing interrupt this open reading frame.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="212">
                    <text>This intronic mutation can abolish normal LHX4 splicing.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="213">
                    <text>This intronic mutation can completely abolishes normal LHX4 splicing, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="214">
                    <text>This intronic mutation has also abolished normal LHX4 splicing associated with formate hydrogenlyase activity.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="215">
                    <text>This intronic mutation promoter completely abolished normal LHX4 splicing, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="216">
                    <text>This intronic mutation promoter completely abolishes normal LHX4 splicing, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="217">
                    <text>This intronic mutation was abolished by normal LHX4 splicing, which was induced by EvgA overexpression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="218">
                    <text>This intronic mutation which abolish normal LHX4 splicing interrupt this open reading frame.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="219">
                    <text>This intronic mutation which abolished normal LHX4 splicing interrupt this open reading frame.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="220">
                    <text>This intronic mutation which has abolished normal LHX4 splicing interrupt this open reading frame.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="221">
                    <text>This intronic mutation will abolish normal LHX4 splicing.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="222">
                    <text>This intronic mutation will also abolish normal LHX4 splicing associated with formate hydrogenlyase activity.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="223">
                    <text>a G-to-A transition at the first nucleotide of intron 2 abolished normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="224">
                    <text>a G-to-A transition at the first nucleotide of intron 2 abolishes normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="225">
                    <text>a G-to-A transition at the first nucleotide of intron 2 also abolish normal splicing associated with formate hydrogenlyase activity.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="226">
                    <text>a G-to-A transition at the first nucleotide of intron 2 also abolished normal splicing associated with formate hydrogenlyase activity.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="227">
                    <text>a G-to-A transition at the first nucleotide of intron 2 being able to abolish normal splicing interrupt this open reading frame.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="228">
                    <text>a G-to-A transition at the first nucleotide of intron 2 can abolish normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="229">
                    <text>a G-to-A transition at the first nucleotide of intron 2 can completely abolishes normal splicing, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="230">
                    <text>a G-to-A transition at the first nucleotide of intron 2 has also abolished normal splicing associated with formate hydrogenlyase activity.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="231">
                    <text>a G-to-A transition at the first nucleotide of intron 2 promoter completely abolished normal splicing, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="232">
                    <text>a G-to-A transition at the first nucleotide of intron 2 promoter completely abolishes normal splicing, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="233">
                    <text>a G-to-A transition at the first nucleotide of intron 2 was abolished by normal splicing, which was induced by EvgA overexpression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="234">
                    <text>a G-to-A transition at the first nucleotide of intron 2 which abolish normal splicing interrupt this open reading frame.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="235">
                    <text>a G-to-A transition at the first nucleotide of intron 2 which abolished normal splicing interrupt this open reading frame.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="236">
                    <text>a G-to-A transition at the first nucleotide of intron 2 which has abolished normal splicing interrupt this open reading frame.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="237">
                    <text>a G-to-A transition at the first nucleotide of intron 2 will abolish normal splicing.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="238">
                    <text>a G-to-A transition at the first nucleotide of intron 2 will also abolish normal splicing associated with formate hydrogenlyase activity.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="239">
                    <text>co-administered DM abolished the CPP effect.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="240">
                    <text>co-administered DM abolishes the CPP effect.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="241">
                    <text>co-administered DM also abolish the CPP effect associated with formate hydrogenlyase activity.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="242">
                    <text>co-administered DM also abolished the CPP effect associated with formate hydrogenlyase activity.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="243">
                    <text>co-administered DM being able to abolish the CPP effect interrupt this open reading frame.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="244">
                    <text>co-administered DM can abolish the CPP effect.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="245">
                    <text>co-administered DM can completely abolishes the CPP effect, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="246">
                    <text>co-administered DM has also abolished the CPP effect associated with formate hydrogenlyase activity.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="247">
                    <text>co-administered DM promoter completely abolished the CPP effect, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="248">
                    <text>co-administered DM promoter completely abolishes the CPP effect, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="249">
                    <text>co-administered DM was abolished by the CPP effect, which was induced by EvgA overexpression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="250">
                    <text>co-administered DM which abolish the CPP effect interrupt this open reading frame.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="251">
                    <text>co-administered DM which abolished the CPP effect interrupt this open reading frame.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="252">
                    <text>co-administered DM which has abolished the CPP effect interrupt this open reading frame.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="253">
                    <text>co-administered DM will abolish the CPP effect.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="254">
                    <text>co-administered DM will also abolish the CPP effect associated with formate hydrogenlyase activity.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="255">
                    <text>cpxA phosphatase activity are abolished by The cpx101 mutation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="256">
                    <text>cpxA phosphatase activity can be abolished by The cpx101 mutation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="257">
                    <text>cpxA phosphatase activity has been abolished by The cpx101 mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="258">
                    <text>cpxA phosphatase activity has been abolished by The cpx101 mutation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="259">
                    <text>cpxA phosphatase activity is abolished by The cpx101 mutation which interrupt this open reading frame.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="260">
                    <text>cpxA phosphatase activity is abolished by The cpx101 mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="261">
                    <text>cpxA phosphatase activity was abolished by The cpx101 mutation which interrupt this open reading frame.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="262">
                    <text>cpxA phosphatase activity was abolished by The cpx101 mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="263">
                    <text>cpxA phosphatase activity were abolished by The cpx101 mutation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="264">
                    <text>cpxA phosphatase activity will be abolished by The cpx101 mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="265">
                    <text>cpxA phosphatase activity will be abolished by The cpx101 mutation.</text>
                    <arg n="0">The cpx101 mutation</arg>
                    <arg n="1">cpxA phosphatase activity</arg>
                </example>
                <example src="REPLACE" no="266">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolished Groucho binding.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="267">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid abolishes Groucho binding.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="268">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid also abolish Groucho binding associated with formate hydrogenlyase activity.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="269">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid also abolished Groucho binding associated with formate hydrogenlyase activity.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="270">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid being able to abolish Groucho binding interrupt this open reading frame.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="271">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid can abolish Groucho binding.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="272">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid can completely abolishes Groucho binding, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="273">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid has also abolished Groucho binding associated with formate hydrogenlyase activity.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="274">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid promoter completely abolished Groucho binding, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="275">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid promoter completely abolishes Groucho binding, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="276">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid was abolished by Groucho binding, which was induced by EvgA overexpression.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="277">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid which abolish Groucho binding interrupt this open reading frame.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="278">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid which abolished Groucho binding interrupt this open reading frame.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="279">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid which has abolished Groucho binding interrupt this open reading frame.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="280">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid will abolish Groucho binding.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="281">
                    <text>mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid will also abolish Groucho binding associated with formate hydrogenlyase activity.</text>
                    <arg n="0">mutating a conserved phenylalanine of the eh1/GEH sequence to glutamic acid</arg>
                    <arg n="1">Groucho binding</arg>
                </example>
                <example src="REPLACE" no="282">
                    <text>normal LHX4 splicing are abolished by This intronic mutation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="283">
                    <text>normal LHX4 splicing can be abolished by This intronic mutation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="284">
                    <text>normal LHX4 splicing has been abolished by This intronic mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="285">
                    <text>normal LHX4 splicing has been abolished by This intronic mutation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="286">
                    <text>normal LHX4 splicing is abolished by This intronic mutation which interrupt this open reading frame.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="287">
                    <text>normal LHX4 splicing is abolished by This intronic mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="288">
                    <text>normal LHX4 splicing was abolished by This intronic mutation which interrupt this open reading frame.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="289">
                    <text>normal LHX4 splicing was abolished by This intronic mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="290">
                    <text>normal LHX4 splicing were abolished by This intronic mutation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="291">
                    <text>normal LHX4 splicing will be abolished by This intronic mutation, which was induced by EvgA overexpression.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="292">
                    <text>normal LHX4 splicing will be abolished by This intronic mutation.</text>
                    <arg n="0">This intronic mutation</arg>
                    <arg n="1">normal LHX4 splicing</arg>
                </example>
                <example src="REPLACE" no="293">
                    <text>normal splicing are abolished by a G-to-A transition at the first nucleotide of intron 2.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="294">
                    <text>normal splicing can be abolished by a G-to-A transition at the first nucleotide of intron 2.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="295">
                    <text>normal splicing has been abolished by a G-to-A transition at the first nucleotide of intron 2, which was induced by EvgA overexpression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="296">
                    <text>normal splicing has been abolished by a G-to-A transition at the first nucleotide of intron 2.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="297">
                    <text>normal splicing is abolished by a G-to-A transition at the first nucleotide of intron 2 which interrupt this open reading frame.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="298">
                    <text>normal splicing is abolished by a G-to-A transition at the first nucleotide of intron 2, which was induced by EvgA overexpression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="299">
                    <text>normal splicing was abolished by a G-to-A transition at the first nucleotide of intron 2 which interrupt this open reading frame.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="300">
                    <text>normal splicing was abolished by a G-to-A transition at the first nucleotide of intron 2, which was induced by EvgA overexpression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="301">
                    <text>normal splicing were abolished by a G-to-A transition at the first nucleotide of intron 2.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="302">
                    <text>normal splicing will be abolished by a G-to-A transition at the first nucleotide of intron 2, which was induced by EvgA overexpression.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="303">
                    <text>normal splicing will be abolished by a G-to-A transition at the first nucleotide of intron 2.</text>
                    <arg n="0">a G-to-A transition at the first nucleotide of intron 2</arg>
                    <arg n="1">normal splicing</arg>
                </example>
                <example src="REPLACE" no="304">
                    <text>one mutation abolished RNA expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="305">
                    <text>one mutation abolishes RNA expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="306">
                    <text>one mutation also abolish RNA expression associated with formate hydrogenlyase activity.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="307">
                    <text>one mutation also abolished RNA expression associated with formate hydrogenlyase activity.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="308">
                    <text>one mutation being able to abolish RNA expression interrupt this open reading frame.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="309">
                    <text>one mutation can abolish RNA expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="310">
                    <text>one mutation can completely abolishes RNA expression, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="311">
                    <text>one mutation has also abolished RNA expression associated with formate hydrogenlyase activity.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="312">
                    <text>one mutation promoter completely abolished RNA expression, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="313">
                    <text>one mutation promoter completely abolishes RNA expression, indicating that this element is essential for MEF2 GATA-4 cooperation.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="314">
                    <text>one mutation was abolished by RNA expression, which was induced by EvgA overexpression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="315">
                    <text>one mutation which abolish RNA expression interrupt this open reading frame.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="316">
                    <text>one mutation which abolished RNA expression interrupt this open reading frame.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="317">
                    <text>one mutation which has abolished RNA expression interrupt this open reading frame.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="318">
                    <text>one mutation will abolish RNA expression.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="319">
                    <text>one mutation will also abolish RNA expression associated with formate hydrogenlyase activity.</text>
                    <arg n="0">one mutation</arg>
                    <arg n="1">RNA expression</arg>
                </example>
                <example src="REPLACE" no="320">
                    <text>the CPP effect are abolished by co-administered DM.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="321">
                    <text>the CPP effect can be abolished by co-administered DM.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="322">
                    <text>the CPP effect has been abolished by co-administered DM, which was induced by EvgA overexpression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="323">
                    <text>the CPP effect has been abolished by co-administered DM.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="324">
                    <text>the CPP effect is abolished by co-administered DM which interrupt this open reading frame.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="325">
                    <text>the CPP effect is abolished by co-administered DM, which was induced by EvgA overexpression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="326">
                    <text>the CPP effect was abolished by co-administered DM which interrupt this open reading frame.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="327">
                    <text>the CPP effect was abolished by co-administered DM, which was induced by EvgA overexpression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="328">
                    <text>the CPP effect were abolished by co-administered DM.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="329">
                    <text>the CPP effect will be abolished by co-administered DM, which was induced by EvgA overexpression.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
                <example src="REPLACE" no="330">
                    <text>the CPP effect will be abolished by co-administered DM.</text>
                    <arg n="0">co-administered DM</arg>
                    <arg n="1">the CPP effect</arg>
                </example>
            </roleset>
        </predicate>
    </framesest>
</PASBIO>
